Abd, A. Elkader

Assessment of the Added Value of Combined Measurement of Immature Platelet Fraction and Schistocyte Count to Differentiate between Pregnancy-associated Thrombotic Thrombocytopenic Purpura and SPE/HELLP Syndrome

Abdelbary, H.

Assessment of the Added Value of Combined Measurement of Immature Platelet Fraction and Schistocyte Count to Differentiate between Pregnancy-associated Thrombotic Thrombocytopenic Purpura and SPE/HELLP Syndrome

Abdul, F. Karim

Long-term Efficacy and Safety of rVIII-SingleChain in Patients with Severe Hemophilia A: Interim Results of an Extension Study

Efficacy and Safety of rVIII-SingleChain in Controlling Surgical Hemostasis

Abola, M.T.

Development of Deep Vein Thrombosis after Achieving Remission in a Patient with Acquired Hemophilia A

Abramov, V.

Venous Thromboembolism Risks Modeling in Burn Patients

Adamkewicz, J.I.

Emicizumab Prophylaxis Administered Once-weekly or Every Two Weeks Provides Effective Bleed Prevention in Persons with Hemophilia A (PwHA) without Inhibitors - Results from the Phase III HAVEN 3 Study

Emicizumab Prophylaxis Administered Once-weekly or Every Two Weeks Provides Effective Bleed Prevention in Persons with Hemophilia A (PwHA) without Inhibitors - Results from the Phase III HAVEN 3 Study

Adenäuer, A.

Detection and Differential Diagnosis of Prekallikrein Deficiency: Genetic Study of New Families and Systematic Review of the Literature

Ageno, W.

Management of Venous Thromboembolism in Routine Clinical Practice - Results from the Global GARFIELD-VTE Registry

Aguiriano, V. Moser

Elevated Bile Acid Levels Induce Tissue Factor Activity in Hepatocytes

Aguzzi, R.

Results from a Phase 3, Multicenter, Noninferiority Study of Ravulizumab (ALXN1210) versus Eculizumab (ECU) in Adult Patients (pts) with Paroxysmal Nocturnal Hemoglubinuria (PNH) Naive to Complement Inhibitors (CI)

Ahmed, M.

Thrombosis after Venous Surgery - Is a Postoperative Heparin Prophylaxis Indicated?

Aisina, R.

Reducing the Side Effects of Thrombolytic Agent by Regulating its Release Rate from Microcapsules

The Influence of Cationic Polyamidoamine Dendrimers on Key Components of Fibrinolysis and Coagulation Systems

Alabid, T.

In Silico Analysis of Single Nucleotide Polymorphism in Human Prothrombin Gene

Alberio, L.

Platelet Activation and Cytosolic Free Potassium Kinetics: A Dynamic Flow Cytometric Monitoring

A New Laboratory Tool to Detect Hypercoagulation and Thrombotic Risk

Systematic Review of Efficacy of Recombinant Factor IX Products for Prophylactic Treatment of Hemophilia B

Albrecht, S.

Acquired von Willebrand Syndrome during Mechanical Circulatory Support and Extracorporeal Membrane Oxygenation: Rapid Onset and the Demand for Point of Care Testing

Al-Dabet, M.M.

Thrombomodulin Regulates Platelet and Extracellular Vesicle Mediated Sterile Inflammation in the Placenta

Thrombomodulin Regulates Platelet and Extracellular Vesicle Mediated Sterile Inflammation in the Placenta

Aldea, C.

Determination of Age Dependent Reference Ranges for PT and aPTT

Alesci, S.

Interim Results of a Non-interventional Study on Efficacy and Tolerability of a VWF/FVIII Concentrate in von Willebrand's Disease

Ali, F.

In Silico Analysis of Single Nucleotide Polymorphism in Human Prothrombin Gene

Aliotta, A.

Platelet Activation and Cytosolic Free Potassium Kinetics: A Dynamic Flow Cytometric Monitoring

A New Laboratory Tool to Detect Hypercoagulation and Thrombotic Risk

Al-Rifai, R.

F8 Heavy vs Light Chain Located Pre-terminal Stop Codon (PTC): Comparing the Intracellular Fate of Endogenous FVIII Variants in IPS Derived Endothelial Cells

Althaus, K.

Severe Thrombocytopenia and Platelet Granule Dysfunction Associated with the Combination of Novel Heterozygous Variants in TUBB1 and ITGB3

The First THROMKID-Plus Inter-laboratory Survey - Standardization and Quality Management of Platelet Light Transmission Aggregometry for the Diagnosis of Inherited Platelet Function Disorders in German-speaking Countries

The First THROMKID-Plus Inter-laboratory Survey - standardization and Quality Management of Platelet Light Transmission Aggregometry for the Diagnosis of Inherited Platelet Function Disorders in German-speaking Countries

A Laboratory Approach to Standardize Luminoaggregometry for Sample Shipment

Combined Acquired Alpha- and Delta Storage Pool Disease in Endstage Renal Failure

Alves, S.

Fibrinogen Concentrate vs Cryoprecipitate in Pseudomyxoma Peritonei Surgery: Interim Results from a Prospective, Randomized, Controlled Phase 2 Study

Amling, M.

Bone Mineral Density and Bone Microstructure in Patients with Haemophilia in Northern Germany: Preliminary Findings of a Single Centre Study

Andres, O.

Use of Targeted High-throughput Sequencing for Genetic Classification of Patients with Bleeding Diathesis and Suspected Platelet Disorder

Use of Targeted High-throughput Sequencing for Genetic Classification of Patients with Bleeding Diathesis and Suspected Platelet Disorder

Andrews, A.

Improving the FVIII Binding Affinity of a Recombinant VWF D'D3-albumin Fusion Molecule Translates to Dosing Benefits with Respect to the Half-life Extension of Co-administered FVIII

Arlt, N.

Quality of Plasma Collected with Closed Plasmapheresis Disposables

Arnold, N.

The Relation between Coagulant and Vascular Function in Adult Survivors of Childhood Cancer

Artunc, F.

Phosphate-induced ORAI1 Expression and Store Operated Ca²⁺ Entry in Megakaryocytes

Ascher, S.

The Gut Microbiota Restricts NETosis in Mesenteric Ischemia-reperfusion Injury

Asikanius, E.

Emicizumab Prophylaxis Administered Once-weekly or Every Two Weeks Provides Effective Bleed Prevention in Persons with Hemophilia A (PwHA) without Inhibitors - Results from the Phase III HAVEN 3 Study

Emicizumab Prophylaxis Administered Once-weekly or Every Two Weeks Provides Effective Bleed Prevention in Persons with Hemophilia A (PwHA) without Inhibitors - Results from the Phase III HAVEN 3 Study

Assinger, A.

Altered Protein Profiles in Platelets of Lupus Anticoagulant Positive Patients - New Players in LA-related Thrombosis?

Aumann, V.

Changes in Hemophilia Treatment in Eastern Germany in the Last Decade - A Survey from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)

Changes in Hemophilia Treatment in Eastern Germany in the Last Decade - A Survey from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)

Aurich, K.

Heterogeneity in Agonist-induced Activation Responses and Thrombus Formation: Differences between Large and Small Platelets

Cold Storage of Platelets in Additive Solution: The Impact of Residual Plasma in Apheresis Platelet Concentrates

Ay, C.

Altered Protein Profiles in Platelets of Lupus Anticoagulant Positive Patients - New Players in LA-related Thrombosis?

Citrullinated Histone H3, a Biomarker for Neutrophil Extracellular Trap Formation, Predicts the Risk of Mortality in Patients with Cancer

Intraperitoneal Activation of Blood Coagulation via Tissue Factor Exposing Extracellular Vesicles in Patients with Liver Disease and Ascites

Programmed Cell Death Ligand 1 and Venous Thromboembolism in Patients with Primary Brain Tumors

Bach, L.

Eleven Relapses in a Cohort of 78 Patients with Immune Thrombotic Thrombocytopenic Purpura (iTTP): Data from the German TTP-Registry

Bagoly, Z.

The Thrombin Generation Test: A Research Method or a Diagnostic Test?

Bakchoul, T.

Severe Thrombocytopenia and Platelet Granule Dysfunction Associated with the Combination of Novel Heterozygous Variants in TUBB1 and ITGB3

Glycan Changes on Platelet and Megakaryocyte: A Potential Impact on Platelet Function and Lifespan in Immune Thrombocytopenia

Phosphate-induced ORAI1 Expression and Store Operated Ca²⁺ Entry in Megakaryocytes

Anti-Glycoprotein V Autoantibodies in Patients with Immune Thrombocytopenia

A New Method to Assess Platelet Activation and Leukocyte-platelet Aggregates in Whole Blood Samples by Flow Cytometry for Clinical Studies

The First THROMKID-Plus Inter-laboratory Survey - Standardization and Quality Management of Platelet Light Transmission Aggregometry for the Diagnosis of Inherited Platelet Function Disorders in German-speaking Countries

The First THROMKID-Plus Inter-laboratory Survey - standardization and Quality Management of Platelet Light Transmission Aggregometry for the Diagnosis of Inherited Platelet Function Disorders in German-speaking Countries

A Laboratory Approach to Standardize Luminoaggregometry for Sample Shipment

Combined Acquired Alpha- and Delta Storage Pool Disease in Endstage Renal Failure

Cold Storage of Platelets in Additive Solution: The Impact of Residual Plasma in Apheresis Platelet Concentrates

Balthazar, L.

Platelet Lipidome and Lipid Induced Thromboinflammatory Actions are Influenced by the CXCL12-CXCR4-CXCR7 Axis

Platelet Lipidome and Lipid Induced Thromboinflammatory Actions are Influenced by the CXCL12-CXCR4-CXCR7 Axis

Banchev, A.

Correlation of Genotype and Phenotype in Congenital FXI Deficiency

Barco, S.

Detection and Differential Diagnosis of Prekallikrein Deficiency: Genetic Study of New Families and Systematic Review of the Literature

Determinants of the Quality of Warfarin Control and Validation of the SAMe-TT2-R2 Score for Acute Venous Thromboembolism. An Analysis of the Hokusai-VTE Trial

Barvencik, F.

Bone Mineral Density and Bone Microstructure in Patients with Haemophilia in Northern Germany: Preliminary Findings of a Single Centre Study

Baschin, M.

Diagnosis of ETV6-mutation Related Thrombocytopenia by Immunofluorescence Microscopy

Basilio, J.

Altered Protein Profiles in Platelets of Lupus Anticoagulant Positive Patients - New Players in LA-related Thrombosis?

Bauer, A.T.

The Endothelial Glycocalyx Contributes to the Anchorage of von Willebrand Factor Fibers to the Vascular Endothelium

Increased Permeability of Tumor Blood Vessels is Triggered by Membrane Attack Complex Activated Neutrophils

Platelet-derived von Willebrand Factor Fosters Intracranial Hypercoagulation in Metastatic Brains of Mice and Humans

Bayat, B.

Anti-Glycoprotein V Autoantibodies in Patients with Immune Thrombocytopenia

Baylon, H.

Successful Therapeutic Management and Delivery in a Pregnancy Complicated by Secondary Evans Syndrome from Systemic Lupus Erythematosus and Concurrent Antiphospholipid Syndrome

Beck, S.

Platelet Lamellipodia Formation is not Required for Thrombus Formation and Stability

Platelet Lamellipodia Formation is not Required for Thrombus Formation and Stability

Becker, R.

Treatment of High-risk Pregnancies with Tinzaparin

Beckmann, L.

Myeloperoxidase (MPO) Inhibits the Procoagulant Activity (PCA) of Extracellular DNA

Beilfuss, M.

Identification of Plasma Cytokine Levels Correlating with FVIII Inhibitor Titer during ITI

Beilfuß, M.

Affinities of FVIII-specific IgG1 and IgG4 during ITI

Bein, G.

Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT): Evidence that Placental rather than Systemic Inflammation is a Modulator of Disease Severity

Anti-Glycoprotein V Autoantibodies in Patients with Immune Thrombocytopenia

Beke, I. Debreceni

The Thrombin Generation Test: A Research Method or a Diagnostic Test?

Bell, J.

Fibrinogen Concentrate vs Cryoprecipitate in Pseudomyxoma Peritonei Surgery: Interim Results from a Prospective, Randomized, Controlled Phase 2 Study

Bender, M.

Platelet Lamellipodia Formation is not Required for Thrombus Formation and Stability

Platelet Lamellipodia Formation is not Required for Thrombus Formation and Stability

Berens, C.

The Activated Protein C (APC) Response to In vivo Thrombin Formation Correlates with the Thrombotic Risk in Factor V Leiden but not in Prothrombin G20210A Carriers

Flow Cytometric Quantification of Human Platelet Membrane Glycoproteins in Citrated Whole Blood

Berghoff, A.-S.

Programmed Cell Death Ligand 1 and Venous Thromboembolism in Patients with Primary Brain Tumors

Bergmann, S.

Von Willebrand factor (vWF) Impairs FVIII-containing Immune Complex Formation and Attenuates Murine FVIII-specific Recall Response In vitro and In vivo

Berning, B.

Emicizumab and its Impact on aPTT-based Assays and FVIII Inhibitor Measurement

Bertaggia, D. Calderara

Platelet Activation and Cytosolic Free Potassium Kinetics: A Dynamic Flow Cytometric Monitoring

A New Laboratory Tool to Detect Hypercoagulation and Thrombotic Risk

Beyer-Westendorf, J.

NOAC Therapy is also Effective and Safe in Patients Older than 80 Years - Results of the Prospective Dresden NOAC Registry (NCT01588119)

Treatment of VTE with Rivaroxaban in Adolescents - Preliminary Findings from the Prospective Dresden NOAC Registry (NCT01588119)

Determinants of the Quality of Warfarin Control and Validation of the SAMe-TT2-R2 Score for Acute Venous Thromboembolism. An Analysis of the Hokusai-VTE Trial

Bhuyan, A.A.M.

Phosphate-induced ORAI1 Expression and Store Operated Ca²⁺ Entry in Megakaryocytes

Bickel, C.

Cost-effectiveness of a Telemedicine-based Coagulation Service versus Routine Medical Care for the Management of Patients Receiving Vitamin K-antagonists - Results from the thrombEVAL Study

Bidlingmaier, C.

Baseline Data from a 24-month Prospective, Non-interventional, Multicentre Study in Germany to Evaluate the Real-world Usage and Effectiveness of rFVIIIFc and rFIXFc in Patients with Haemophilia A or B (PREVENT)

GEPHARD - the PUP Cohort of the `Standing Commission Paediatrics of the Society for Thrombosis and Haemostasis Research´ - A Progress Report

Switching to rVIII-SingleChain Ensures Bleeding Protection and may Reduce Injection Frequency or Consumption in Hemophilia A Patients: Real-world Clinical Experience in Adults/Adolescents and Pediatric Patients

Bieberle, I.

Successful Control of Bleeding with Emicizumab in Aquired Haemophilia A: A Case Report

Billing, H.

Combined Acquired Alpha- and Delta Storage Pool Disease in Endstage Renal Failure

Binder, N.B.

Performance Evaluation of Automated C1 Esterase Inhibitor Measurement with TECHNOCHROM®C1INH on Ceveron®alpha

Monitoring of Emicizumab and Factor VIII Concentrate Interaction

Performance Evaluation of the New Screening Assay for ADAMTS-13 Activity

Birschmann, I.

Protocol for Safe Management of Patients under DOAC Therapy before Cardiothoracic Surgery Compared to Patients Undergoing VKA or No Anticoagulation Therapy

Establishment of Various Specific Parameters for the Routine Diagnostics in Patients with Glanzmann Thrombasthenia

Platelet Complement C3α-chain Differs from Plasma C3α

Bischoff, S.

GECAT - German Evaluation of Cancer associated Thrombosis: A Prospective Register Trial for Patients with Active Cancer and Venous Thromboembolism in Berlin

Biswas, A.

Calcium Binding to FXIII-A Subunit: Unique Characteristics

The FXIIIA₂B₂ Heterotetrameric Complex Structure: Unequal Pairing within a Symmetric Complex

A Novel Missense Mutation in ITGB3 Gene Causing Autosomal Dominant Glanzmann Thrombasthenia

Bitkova, E.

Hemorheological Parameters as Predictors of Venous Thromboembolism in Burned Patients

Block, A.C.

Severe Arterial Forearm Thrombosis in an 11-year-old Girl with Homozygous Antithrombin Deficiency typ IIb Budapest 3 and Mild Factor VII Deficiency Due to Homozygous Polymorphisms in the Factor 7 Gene and Antithrombotic Treatment

Blumentritt, C.

Diagnosis of ETV6-mutation Related Thrombocytopenia by Immunofluorescence Microscopy

Böckelmann, D.

Novel likely Pathogenic Variant in the Second Calcium Binding Domain of αIIb (Subunit of αIIbβ3) in a Patient with Glanzmann Thrombasthenia

Bocksrucker, C.

Immunoadsorption for the Treatment of Acquired Haemophilia: A Systematic Review

Bode, C.

The Inflammatory Landscape during Myocardial Reperfusion Injury Depends on Distinct Neutrophil Phenotypes

Platelet-leukocyte Complex Formation is Associated with, but Dispensable for Myocardial Ischemia Reperfusion Injury

Platelet Serotonin in Arterial and Deep Vein Thrombosis

Bogdanova, A.

Correlation between Indicators of Endogenous Vascular Regulation and System of Hemostasis in Burn Patients

Böhm, D.

Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT): Evidence that Placental rather than Systemic Inflammation is a Modulator of Disease Severity

Bommer, M.

Incidence of Acquired Thrombotic Thrombocytopenic Purpura Episodes in adults in Germany: Results of a Hospital Level Study and Projection to National Estimates

Borisov, V.

New Oral Anticoagulants for Prevention of Complications of Venous Thromboembolism in Burn Patients

Hemorheological Parameters as Predictors of Venous Thromboembolism in Burned Patients

Venous Thromboembolism Risks Modeling in Burn Patients

Correlation between Indicators of Endogenous Vascular Regulation and System of Hemostasis in Burn Patients

Nanosilver Induce Platelet Pro-thrombotic Ability in Norm and Pathology

Diagnostic Coagulopathy in Burn Patients in the Acute Period of Thermal Injury

Borovkova, N.

Nanosilver Induce Platelet Pro-thrombotic Ability in Norm and Pathology

Borst, O.

Platelet-leukocyte Complex Formation is Associated with, but Dispensable for Myocardial Ischemia Reperfusion Injury

Bosbach, S.

Are Retrospective Patient Chart Audits an Affordable and Reliable Answer to healthcare data needs? Assessing the Ground Reality

Bosher, S.

A Laboratory Approach to Standardize Luminoaggregometry for Sample Shipment

Combined Acquired Alpha- and Delta Storage Pool Disease in Endstage Renal Failure

Brainsky, A.

Long-term Efficacy and Safety of rVIII-SingleChain in Patients with Severe Hemophilia A: Interim Results of an Extension Study

Long-term Safety and Efficacy of rIX-FP in Patients with Hemophilia B: Intermediate Results from a Phase IIIb Extension Study

Efficacy and Safety of rVIII-SingleChain in Controlling Surgical Hemostasis

Brandao, L.R.

Recurrent Pediatric Stroke: The Role of Thrombophilia in a Large International Pediatric Stroke Population

Recurrent Pediatric Stroke: The Role of Thrombophilia in a Large International Pediatric Stroke Population

Braun, A.

Platelet Serotonin in Arterial and Deep Vein Thrombosis

Breheny, D.

Effects of WSCM, eVCM and Nicotine on monocyte adhesion to human aortic endothelial cells

Brehm, M.A.

Investigation of VWD Type 2B Variants by Light Transmission Aggregometry

Brenner, H.

Plasma Levels of Soluble CLEC-2 in Patients with Different Solid Tumors

Brigin, P.

Diagnostic Coagulopathy in Burn Patients in the Acute Period of Thermal Injury

Brodde, M.

Some Plasma Derived FVIII Concentrates Activated FXII Leading to Kallikrein and Bradykinin Formation In vitro, while Recombinant FVIII Concentrates did not

Brouns, S.

Heterogeneity in Agonist-induced Activation Responses and Thrombus Formation: Differences between Large and Small Platelets

Bruce, Ewenstein

Results from a Phase 3, Randomized, Multicenter Study of Rurioctocog alfa Pegol PK-Guided Prophylaxis Targeting 2 FVIII Trough Levels in Patients with Severe Hemophilia a (Propel Study)

Bruegel, M.

Emicizumab and its Impact on aPTT-based Assays and FVIII Inhibitor Measurement

Bugert, P.

Correlation of CLEC1B Gene Polymorphisms with Plasma Levels of Soluble CLEC-2 in Healthy Individuals

Plasma Levels of Soluble CLEC-2 in Patients with Different Solid Tumors

Bujan, W.

Emicizumab Prophylaxis Administered Once-weekly or Every Two Weeks Provides Effective Bleed Prevention in Persons with Hemophilia A (PwHA) without Inhibitors - Results from the Phase III HAVEN 3 Study

Emicizumab Prophylaxis Administered Once-weekly or Every Two Weeks Provides Effective Bleed Prevention in Persons with Hemophilia A (PwHA) without Inhibitors - Results from the Phase III HAVEN 3 Study

Burg-Roderfeld, M.

Anti-Glycoprotein V Autoantibodies in Patients with Immune Thrombocytopenia

Bursasiu, S.

Determination of Age Dependent Reference Ranges for PT and aPTT

Bütikofer, L.

More severe ADAMTS13 Deficiency in Homozygous versus Compound Heterozygous Carriers of the ADAMTS13 c.4143_4144dupA Mutation in Congenital Thrombotic Thrombocytopenic Purpura (cTTP): Impact on Disease Onset?

Byelinska, I.

Subacute Megakaryocytopoietic Toxicity of Maleimide Derivative with Antitumor Activity

Callaghan, M.

Emicizumab Prophylaxis Administered Once-weekly or Every Two Weeks Provides Effective Bleed Prevention in Persons with Hemophilia A (PwHA) without Inhibitors - Results from the Phase III HAVEN 3 Study

Emicizumab Prophylaxis Administered Once-weekly or Every Two Weeks Provides Effective Bleed Prevention in Persons with Hemophilia A (PwHA) without Inhibitors - Results from the Phase III HAVEN 3 Study

Callewaert, F.

Safety Results Normalized to Time of Exposure during the Phase 3 HERCULES Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura

Risk Factors and Manageability of the Mucocutaneous Bleeding Profile Observed in aTTP Patients Treated with Caplacizumab during the Phase III HERCULES Study

Safety Results Normalized to Time of Exposure during the Phase 3 HERCULES Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura

Cao, H.

Phosphate-induced ORAI1 Expression and Store Operated Ca²⁺ Entry in Megakaryocytes

Castaman, G.

Phase 2b Trial of AMT-061 (AAV5-Padua hFIX): Translation into Humans of an Enhanced Gene Transfer Vector for Adults with Severe or Moderate-severe Hemophilia B

HOPE-B: Study Design of a Phase III trial of an Investigational Gene Therapy AMT-061 in Subjects with Severe or Moderately Severe Hemophilia B

Cataland, S.

Safety Results Normalized to Time of Exposure during the Phase 3 HERCULES Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura

Risk Factors and Manageability of the Mucocutaneous Bleeding Profile Observed in aTTP Patients Treated with Caplacizumab during the Phase III HERCULES Study

Safety Results Normalized to Time of Exposure during the Phase 3 HERCULES Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura

Cebo, M.

Platelet Lipidome and Lipid Induced Thromboinflammatory Actions are Influenced by the CXCL12-CXCR4-CXCR7 Axis

Platelet Lipidome and Lipid Induced Thromboinflammatory Actions are Influenced by the CXCL12-CXCR4-CXCR7 Axis

Cermakova, Z.

More severe ADAMTS13 Deficiency in Homozygous versus Compound Heterozygous Carriers of the ADAMTS13 c.4143_4144dupA Mutation in Congenital Thrombotic Thrombocytopenic Purpura (cTTP): Impact on Disease Onset?

Cerrado, J.P.

Development of Deep Vein Thrombosis after Achieving Remission in a Patient with Acquired Hemophilia A

Cesari, E.

Novel likely Pathogenic Variant in the Second Calcium Binding Domain of αIIb (Subunit of αIIbβ3) in a Patient with Glanzmann Thrombasthenia

Chasakova, K.

The Comparison of Manual and Automatic Interference Determination on Coagulometers ACL Top 750 CTS and Roche Cobas t511 for Routine Coagulation Tests

Chatterjee, M.

Platelet Lipidome and Lipid Induced Thromboinflammatory Actions are Influenced by the CXCL12-CXCR4-CXCR7 Axis

Platelet Lipidome and Lipid Induced Thromboinflammatory Actions are Influenced by the CXCL12-CXCR4-CXCR7 Axis

Claar, P.

Improving the FVIII Binding Affinity of a Recombinant VWF D'D3-albumin Fusion Molecule Translates to Dosing Benefits with Respect to the Half-life Extension of Co-administered FVIII

Cladder-Micus, L.

The Endothelial Glycocalyx Contributes to the Anchorage of von Willebrand Factor Fibers to the Vascular Endothelium

Cohen, A.

Determinants of the Quality of Warfarin Control and Validation of the SAMe-TT2-R2 Score for Acute Venous Thromboembolism. An Analysis of the Hokusai-VTE Trial

Coldewey, M.

Cost-effectiveness of a Telemedicine-based Coagulation Service versus Routine Medical Care for the Management of Patients Receiving Vitamin K-antagonists - Results from the thrombEVAL Study

Conti, L.

Detection and Differential Diagnosis of Prekallikrein Deficiency: Genetic Study of New Families and Systematic Review of the Literature

Cooper, N.

Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT): Evidence that Placental rather than Systemic Inflammation is a Modulator of Disease Severity

Anti-Glycoprotein V Autoantibodies in Patients with Immune Thrombocytopenia

Coppens, M.

Determinants of the Quality of Warfarin Control and Validation of the SAMe-TT2-R2 Score for Acute Venous Thromboembolism. An Analysis of the Hokusai-VTE Trial

Coppo, P.

Safety Results Normalized to Time of Exposure during the Phase 3 HERCULES Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura

Risk Factors and Manageability of the Mucocutaneous Bleeding Profile Observed in aTTP Patients Treated with Caplacizumab during the Phase III HERCULES Study

Safety Results Normalized to Time of Exposure during the Phase 3 HERCULES Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura

Czogalla, K.J.

Determination of ɣ-carboxylation Pattern of Different Vitamin K Dependent Proteins with Respect to VKCFD1 Phenotype

Derivation of Patient Specific iPSCs and iHEP Cell Lines as a Tool to Investigate VKCFD2 in a Native Cellular Environment

Damokosh, A.

Results from a Phase 3, Multicenter, Noninferiority Study of Ravulizumab (ALXN1210) versus Eculizumab (ECU) in Adult Patients (pts) with Paroxysmal Nocturnal Hemoglubinuria (PNH) Naive to Complement Inhibitors (CI)

Daoud, M.

Interim Results of a Non-interventional Study on Efficacy and Tolerability of a VWF/FVIII Concentrate in von Willebrand's Disease

Darius, H.

Management of Venous Thromboembolism in Routine Clinical Practice - Results from the Global GARFIELD-VTE Registry

Daskalakis, M.

Immunoadsorption for the Treatment of Acquired Haemophilia: A Systematic Review

Daub, U.

Haemophilia and Osteoporosis Management in Germany

Daufenbach, J.

Coagulation Factor VIII with Reduced Immunogenicity via a Direct De-immunization Approach

Davis, J.

Systematic Review of Efficacy of Recombinant Factor IX Products for Prophylactic Treatment of Hemophilia B

De Groot, A.S.

Coagulation Factor VIII with Reduced Immunogenicity via a Direct De-immunization Approach

Deindl, E.

Inflammatory Function of Ribosomal RNA-containing Microvesicles from Mast Cells

de la Rubia, J.

Safety Results Normalized to Time of Exposure during the Phase 3 HERCULES Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura

Risk Factors and Manageability of the Mucocutaneous Bleeding Profile Observed in aTTP Patients Treated with Caplacizumab during the Phase III HERCULES Study

Safety Results Normalized to Time of Exposure during the Phase 3 HERCULES Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura

Dempfle, C.-E.

Interim Results of a Non-interventional Study on Efficacy and Tolerability of a VWF/FVIII Concentrate in von Willebrand's Disease

Denecke, T.

Systematic Comparison of MRI and ultrasound scores to Assess Arthropathy in Children and Adolescents with Hemophilia

Denisova, T.

The Kinetics of Platelet-derived Microparticles in Patients with ST Segment Elevation Acute Myocardial Infarction under Pharmacological Suppression of Platelet Aggregation

Deppisch, C.

Congenital Antithrombin Deficiency Type II: A Case Report

Detering, C.

Thermography as a Component of Telemedicine for Diagnosis, Therapy and Follow-up of Joint Bleeding, Soft-tissue Bleeding and Micro-bleeding

deVeber, G.

Recurrent Pediatric Stroke: The Role of Thrombophilia in a Large International Pediatric Stroke Population

Recurrent Pediatric Stroke: The Role of Thrombophilia in a Large International Pediatric Stroke Population

de Winter, H.

Safety Results Normalized to Time of Exposure during the Phase 3 HERCULES Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura

Risk Factors and Manageability of the Mucocutaneous Bleeding Profile Observed in aTTP Patients Treated with Caplacizumab during the Phase III HERCULES Study

Safety Results Normalized to Time of Exposure during the Phase 3 HERCULES Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura

de Wit, M.

GECAT - German Evaluation of Cancer associated Thrombosis: A Prospective Register Trial for Patients with Active Cancer and Venous Thromboembolism in Berlin

Dhalluin, C.

Emicizumab Prophylaxis Administered Once-weekly or Every Two Weeks Provides Effective Bleed Prevention in Persons with Hemophilia A (PwHA) without Inhibitors - Results from the Phase III HAVEN 3 Study

Emicizumab Prophylaxis Administered Once-weekly or Every Two Weeks Provides Effective Bleed Prevention in Persons with Hemophilia A (PwHA) without Inhibitors - Results from the Phase III HAVEN 3 Study

Dicke, C.

Myeloperoxidase (MPO) Inhibits the Procoagulant Activity (PCA) of Extracellular DNA

Di Prinzio, G.

Prompt Response and Long Term Remission of Refractory MGUS Related Acquired Hemophilia with Bortezomib

Cancer Induced Hyperfibronolysis in a 59-year-old Woman with Congenital Hyperfibrinogenemia

Experience in the Treatment of Acquired Haemophilia A (AHA) in 26 Patients in Relation to Bleeding Control and Induction of Immune Tolerance

Dittrich, M.

Protocol for Safe Management of Patients under DOAC Therapy before Cardiothoracic Surgery Compared to Patients Undergoing VKA or No Anticoagulation Therapy

Djambas, C. Khayat

Efficacy and Safety of rVIII-SingleChain in Controlling Surgical Hemostasis

Dodt, J.

Calcium Binding to FXIII-A Subunit: Unique Characteristics

Dolotovskaya, P.

The Kinetics of Platelet-derived Microparticles in Patients with ST Segment Elevation Acute Myocardial Infarction under Pharmacological Suppression of Platelet Aggregation

Donado, R.I.

Successful Therapeutic Management and Delivery in a Pregnancy Complicated by Secondary Evans Syndrome from Systemic Lupus Erythematosus and Concurrent Antiphospholipid Syndrome

Douma, Y.

Development of an Adherence Questionnaire for Haemophilia Patients of the German Health System

Douxfils, J.

Determinants of the Quality of Warfarin Control and Validation of the SAMe-TT2-R2 Score for Acute Venous Thromboembolism. An Analysis of the Hokusai-VTE Trial

Dower, S.

Improving the FVIII Binding Affinity of a Recombinant VWF D'D3-albumin Fusion Molecule Translates to Dosing Benefits with Respect to the Half-life Extension of Co-administered FVIII

Drechsler, S.

Plasmin-induced Alterations to Platelet GPIIb/IIIa Receptors Impair Secondary Blood Clot Firmness

Duerschmied, D.

The Inflammatory Landscape during Myocardial Reperfusion Injury Depends on Distinct Neutrophil Phenotypes

Platelet Serotonin in Arterial and Deep Vein Thrombosis

Dufner, B.

Platelet-leukocyte Complex Formation is Associated with, but Dispensable for Myocardial Ischemia Reperfusion Injury

Dumagay, T.

Development of Deep Vein Thrombosis after Achieving Remission in a Patient with Acquired Hemophilia A

Dürr, N.

Glioblastoma Cell Adhesion and Invasion in Fibrin is Promoted through β₃ Integrin

Dürschmied, D.

Platelet-leukocyte Complex Formation is Associated with, but Dispensable for Myocardial Ischemia Reperfusion Injury

Eberl, W.

GEPHARD - the PUP Cohort of the `Standing Commission Paediatrics of the Society for Thrombosis and Haemostasis Research´ - A Progress Report

Congenital Protein C Deficiency: Delayed Treatment of 14 Year Old Girl causes Prolonged Treatment, Several Complications and Unfavorable Results

Eckerle, S.

The Relation between Coagulant and Vascular Function in Adult Survivors of Childhood Cancer

Eekels, J.J.M.

Ticagrelor Inhibits the Functional Assay for Heparin-induced Thrombocytopenia

Eggebrecht, L.

Cost-effectiveness of a Telemedicine-based Coagulation Service versus Routine Medical Care for the Management of Patients Receiving Vitamin K-antagonists - Results from the thrombEVAL Study

Eichinger, S.

Risk and Determinants of Provoked Recurrent Venous Thromboembolism: A Prospective Cohort Study

Eichler, H.

Comparison of Electronic Documentation with Smart Medication^tm between 2014 and 2017

Glioblastoma Cell Adhesion and Invasion in Fibrin is Promoted through β₃ Integrin

Treatment Pattern and Pain Related to Joint Bleeds and Non-joint Bleeds - real Life Data According to Electronic Diary Smart-medication^TM

Eischer, L.

Risk and Determinants of Provoked Recurrent Venous Thromboembolism: A Prospective Cohort Study

Elbracht, M.

Plasma-derived Factor X Therapy for Treatment of Intracranial Bleeding in a Patient with Factor X Deficiency: A Case Report

El-Gamal, R.

Assessment of the Added Value of Combined Measurement of Immature Platelet Fraction and Schistocyte Count to Differentiate between Pregnancy-associated Thrombotic Thrombocytopenic Purpura and SPE/HELLP Syndrome

Eller, T.

Protocol for Safe Management of Patients under DOAC Therapy before Cardiothoracic Surgery Compared to Patients Undergoing VKA or No Anticoagulation Therapy

El-Maarri, O.

Methylation Profile of Adult and Fetal FVIII Secreting Endothelial Cells in Comparison to other Endothelial Cells

F8 Heavy vs Light Chain Located Pre-terminal Stop Codon (PTC): Comparing the Intracellular Fate of Endogenous FVIII Variants in IPS Derived Endothelial Cells

El-Mubark, A.

In Silico Analysis of Single Nucleotide Polymorphism in Human Prothrombin Gene

Elsemüller, A.-K.

Inflammatory Function of Ribosomal RNA-containing Microvesicles from Mast Cells

Engelmaier, A.

Selective Measurement of Human Factor IX Padua Activity in Citrated Goat Plasma

Selective Measurement of Human Factor VIII Activity in the Citrated Plasma of Laboratory Animals

Engelmann, B.

Pancreatic Tumor Microvesicles Invade Immune Cells via CD36 and Distinctly Promote Tumor-associated Deep Vein Thrombosis

Entezami, M.

Treatment of High-risk Pregnancies with Tinzaparin

Erdel, V.

FibrinoQuick - A Rapid Fibrinogen Assay for Patient Blood Management

Ernemann, U.

Congenital Antithrombin Deficiency Type II: A Case Report

Escuriola-Ettingshausen, C.

Safety and Efficacy of Turoctocog Alfa in Severe and Moderately Severe Previously Treated Patients with Haemophilia A: Interim Results after >4,000 Exposure Days (Guardian 5)

GEPHARD - the PUP Cohort of the `Standing Commission Paediatrics of the Society for Thrombosis and Haemostasis Research´ - A Progress Report

Haemophilia A Prophylaxis with FVIII in Real-life: Snapshot Analysis on the Observational Study “Prevention of Bleeding in Haemophilia A by Prophylactic Treatment with Octanate^®, Wilate^® or Nuwiq^® - NIS Previq”

Esteves, M. Pereira

Immunoadsorption for the Treatment of Acquired Haemophilia: A Systematic Review

Esztergár, I.A.

Determination of Age Dependent Reference Ranges for PT and aPTT

Etemad, M.

Correlation of CLEC1B Gene Polymorphisms with Plasma Levels of Soluble CLEC-2 in Healthy Individuals

Plasma Levels of Soluble CLEC-2 in Patients with Different Solid Tumors

Ewing, N.

Identification of Plasma Cytokine Levels Correlating with FVIII Inhibitor Titer during ITI

Faber, J.

The Relation between Coagulant and Vascular Function in Adult Survivors of Childhood Cancer

Falter, T.

Sera of Syphilis Patients Contain Antiphospholipid Antibodies with Procoagulant Properties

Eleven Relapses in a Cohort of 78 Patients with Immune Thrombotic Thrombocytopenic Purpura (iTTP): Data from the German TTP-Registry

Farah, I.

In Silico Analysis of Single Nucleotide Polymorphism in Human Prothrombin Gene

Farken, A.

The Endothelial Glycocalyx Contributes to the Anchorage of von Willebrand Factor Fibers to the Vascular Endothelium

Farrag, A.

Plasma-derived Factor X Therapy for Treatment of Intracranial Bleeding in a Patient with Factor X Deficiency: A Case Report

Fayek, M.

Assessment of the Added Value of Combined Measurement of Immature Platelet Fraction and Schistocyte Count to Differentiate between Pregnancy-associated Thrombotic Thrombocytopenic Purpura and SPE/HELLP Syndrome

Feddern, J.

Interim Results of a Non-interventional Study on Efficacy and Tolerability of a VWF/FVIII Concentrate in von Willebrand's Disease

Haemophilia A Prophylaxis with FVIII in Real-life: Snapshot Analysis on the Observational Study “Prevention of Bleeding in Haemophilia A by Prophylactic Treatment with Octanate^®, Wilate^® or Nuwiq^® - NIS Previq”

Feinauer, M.

Platelet-derived von Willebrand Factor Fosters Intracranial Hypercoagulation in Metastatic Brains of Mice and Humans

Felbor, U.

Thrombocytopenia Related to Defects in Platelet Cytoskeleton Regulation Genes

Feldkamp, T.

Incidence of Acquired Thrombotic Thrombocytopenic Purpura Episodes in adults in Germany: Results of a Hospital Level Study and Projection to National Estimates

Feussner, A.

Population Pharmacokinetic Analysis of Recombinant Fusion Protein Linking Coagulation Factor IX with Recombinant Albumin (rIX-FP) in Adult and Pediatric Patients with Severe Hemophilia B

Fields, W.

Effects of WSCM, eVCM and Nicotine on monocyte adhesion to human aortic endothelial cells

Fischer, L.

Changes in Hemophilia Treatment in Eastern Germany in the Last Decade - A Survey from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)

Changes in Hemophilia Treatment in Eastern Germany in the Last Decade - A Survey from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)

Fischer, R.

Comparison of Electronic Documentation with Smart Medication^tm between 2014 and 2017

Smart medication^tm - A Pilot Study for Investigating the Feasibility of Speech Recognition of Natural Language to Access Electronic Patient Diary

Impact of GDPR (DSGVO) on Smart Medication™ Electronic Patient Diary

Treatment Pattern and Pain Related to Joint Bleeds and Non-joint Bleeds - real Life Data According to Electronic Diary Smart-medication^TM

Fischer, S.

Inflammatory Function of Ribosomal RNA-containing Microvesicles from Mast Cells

Fleck, E.

In vitro and In vivo Validation of a Laboratory Assay for Monitoring Survival of Transfused Platelets: Tracking HLA Mismatch between Donor and Recipient

Flieder, T.

Protocol for Safe Management of Patients under DOAC Therapy before Cardiothoracic Surgery Compared to Patients Undergoing VKA or No Anticoagulation Therapy

Establishment of Various Specific Parameters for the Routine Diagnostics in Patients with Glanzmann Thrombasthenia

Platelet Complement C3α-chain Differs from Plasma C3α

Flockton, H.

Effects of WSCM, eVCM and Nicotine on monocyte adhesion to human aortic endothelial cells

Flommersfeld, S.

Successful Control of Bleeding with Emicizumab in Aquired Haemophilia A: A Case Report

Forin, F.

Derivation of Patient Specific iPSCs and iHEP Cell Lines as a Tool to Investigate VKCFD2 in a Native Cellular Environment

Fox, V.

Protocol for Safe Management of Patients under DOAC Therapy before Cardiothoracic Surgery Compared to Patients Undergoing VKA or No Anticoagulation Therapy

Franke, A.

Role of Gender and ABO-blood Group in White Adolescents and Young Adult Patients with First VTE Onset

Franke, B.

Direct Oral Anticoagulants in Patients with Antiphospholipid Syndrome: Results from a Retrospective Study in a Real-life Patient Cohort

Direct Oral Anticoagulants in Patients with Antiphospholipid Syndrome: Results from a Retrospective Study in a Real-life Patient Cohort

Friedman, K.D.

More severe ADAMTS13 Deficiency in Homozygous versus Compound Heterozygous Carriers of the ADAMTS13 c.4143_4144dupA Mutation in Congenital Thrombotic Thrombocytopenic Purpura (cTTP): Impact on Disease Onset?

Fritsch, G.

Plasmin-induced Alterations to Platelet GPIIb/IIIa Receptors Impair Secondary Blood Clot Firmness

Fujimura, Y.

More severe ADAMTS13 Deficiency in Homozygous versus Compound Heterozygous Carriers of the ADAMTS13 c.4143_4144dupA Mutation in Congenital Thrombotic Thrombocytopenic Purpura (cTTP): Impact on Disease Onset?

Füreder, W.

Results from a Phase 3, Multicenter, Noninferiority Study of Ravulizumab (ALXN1210) versus Eculizumab (ECU) in Adult Patients (pts) with Paroxysmal Nocturnal Hemoglubinuria (PNH) Naive to Complement Inhibitors (CI)

Furman, N.

The Kinetics of Platelet-derived Microparticles in Patients with ST Segment Elevation Acute Myocardial Infarction under Pharmacological Suppression of Platelet Aggregation

Gambaryan, S.

The Direct Thrombin Inhibitors Dabigatran and Lepirudin Inhibit GPIbα-mediated Platelet Aggregation

Ganesan, V.

Recurrent Pediatric Stroke: The Role of Thrombophilia in a Large International Pediatric Stroke Population

Recurrent Pediatric Stroke: The Role of Thrombophilia in a Large International Pediatric Stroke Population

Gasper, S.

Development and Validation of a Novel Flow Cytometric Assay for Quantification of Plasma ADAMTS-13 Activity (AD13a-FCA)

Gauchel, N.

Platelet Serotonin in Arterial and Deep Vein Thrombosis

Gawaz, M.

Platelet Lipidome and Lipid Induced Thromboinflammatory Actions are Influenced by the CXCL12-CXCR4-CXCR7 Axis

Platelet Lipidome and Lipid Induced Thromboinflammatory Actions are Influenced by the CXCL12-CXCR4-CXCR7 Axis

Phosphate-induced ORAI1 Expression and Store Operated Ca²⁺ Entry in Megakaryocytes

Gebhart, J.

Altered Protein Profiles in Platelets of Lupus Anticoagulant Positive Patients - New Players in LA-related Thrombosis?

Geisen, C.

In vitro and In vivo Validation of a Laboratory Assay for Monitoring Survival of Transfused Platelets: Tracking HLA Mismatch between Donor and Recipient

Geisen, U.

Successful Treatment with Emicizumab of a Patient with Severe Haemophilia A and Factor VIII Inhibitors

George, J.N.

More severe ADAMTS13 Deficiency in Homozygous versus Compound Heterozygous Carriers of the ADAMTS13 c.4143_4144dupA Mutation in Congenital Thrombotic Thrombocytopenic Purpura (cTTP): Impact on Disease Onset?

Gerchkovich, K.

Reducing the Side Effects of Thrombolytic Agent by Regulating its Release Rate from Microcapsules

Gerhards, C.

Correlation of CLEC1B Gene Polymorphisms with Plasma Levels of Soluble CLEC-2 in Healthy Individuals

Gessner, M.

Combined Acquired Alpha- and Delta Storage Pool Disease in Endstage Renal Failure

Ghosh, S.

Determination of ɣ-carboxylation Pattern of Different Vitamin K Dependent Proteins with Respect to VKCFD1 Phenotype

Gleixner, K.

Emicizumab for the Treatment of Acquired Hemophilia A: Lessons Learned from 4 very Different Cases

Göbel, S.

Cost-effectiveness of a Telemedicine-based Coagulation Service versus Routine Medical Care for the Management of Patients Receiving Vitamin K-antagonists - Results from the thrombEVAL Study

Goldmann, G.

Prompt Response and Long Term Remission of Refractory MGUS Related Acquired Hemophilia with Bortezomib

Haemophilia and Osteoporosis Management in Germany

Cancer Induced Hyperfibronolysis in a 59-year-old Woman with Congenital Hyperfibrinogenemia

Experience in the Treatment of Acquired Haemophilia A (AHA) in 26 Patients in Relation to Bleeding Control and Induction of Immune Tolerance

Switching to rVIII-SingleChain Ensures Bleeding Protection and may Reduce Injection Frequency or Consumption in Hemophilia A Patients: Real-world Clinical Experience in Adults/Adolescents and Pediatric Patients

Golovko, L.

The Assessment of the Frequency of Complications in the Analysis of the Time Interval between Anticoagulants and Haemostatic Drugs among Patients after the Total Knee and Hip Replacement

Gorzelanny, C.

The Endothelial Glycocalyx Contributes to the Anchorage of von Willebrand Factor Fibers to the Vascular Endothelium

Increased Permeability of Tumor Blood Vessels is Triggered by Membrane Attack Complex Activated Neutrophils

Platelet-derived von Willebrand Factor Fosters Intracranial Hypercoagulation in Metastatic Brains of Mice and Humans

Gottstein, S.

Successful Immune Tolerance Induction in Two Patients with Severe Haemophilia B with Inhibitors and Anaphylaxis

Graf, C.

EPCR Raft Signaling Controls Activity of Hematopoietic Progenitor and Stem Cells

Granja, T.

Acquired von Willebrand Syndrome during Mechanical Circulatory Support and Extracorporeal Membrane Oxygenation: Rapid Onset and the Demand for Point of Care Testing

Granziera, S.

Determinants of the Quality of Warfarin Control and Validation of the SAMe-TT2-R2 Score for Acute Venous Thromboembolism. An Analysis of the Hokusai-VTE Trial

Greimel, T.

Elevated Bile Acid Levels Induce Tissue Factor Activity in Hepatocytes

Greinacher, A.

Single-molecule Labeling and Tracking of FcγRIIA on Human Platelets Reveals Differential Mobility Dynamics, which Depends on Platelet Cytoskeletal Integrity

Distinct Binding Characteristics of Pathogenic Anti-platelet Factor 4/polyanion Antibodies to their Antigen Coated on Different Substrates

Single-molecule Labeling and Tracking of FcγRIIA on Human Platelets Reveals Differential Mobility Dynamics, which Depends on Platelet Cytoskeletal Integrity

Diagnosis of ETV6-mutation Related Thrombocytopenia by Immunofluorescence Microscopy

Ticagrelor Inhibits the Functional Assay for Heparin-induced Thrombocytopenia

Heterogeneity in Agonist-induced Activation Responses and Thrombus Formation: Differences between Large and Small Platelets

Cold Storage of Platelets in Additive Solution: The Impact of Residual Plasma in Apheresis Platelet Concentrates

Grewe, B.

Measurement of Thrombophilic Profile under Removing DOACs from Plasma Samples

Griesser, C.

Prevalence of Paroxysmal Nocturnal Hemoglobinuria in Children with Thrombosis - A Retrospective Cohort Study

Griffith, M.

Performance Evaluation of the New Screening Assay for ADAMTS-13 Activity

Grill, A.

The Gut Microbiota Restricts NETosis in Mesenteric Ischemia-reperfusion Injury

Grilz, E.

Citrullinated Histone H3, a Biomarker for Neutrophil Extracellular Trap Formation, Predicts the Risk of Mortality in Patients with Cancer

Grotius, K.

Platelet-leukocyte Complex Formation is Associated with, but Dispensable for Myocardial Ischemia Reperfusion Injury

Grottke, O.

Plasma-derived Factor X Therapy for Treatment of Intracranial Bleeding in a Patient with Factor X Deficiency: A Case Report

Gualandro, S.

Results from a Phase 3, Multicenter, Noninferiority Study of Ravulizumab (ALXN1210) versus Eculizumab (ECU) in Adult Patients (pts) with Paroxysmal Nocturnal Hemoglubinuria (PNH) Naive to Complement Inhibitors (CI)

Gummert, J.

Protocol for Safe Management of Patients under DOAC Therapy before Cardiothoracic Surgery Compared to Patients Undergoing VKA or No Anticoagulation Therapy

Gutti, R.

Phosphate-induced ORAI1 Expression and Store Operated Ca²⁺ Entry in Megakaryocytes

Haarmeijer, B.

Von Willebrand factor (vWF) Impairs FVIII-containing Immune Complex Formation and Attenuates Murine FVIII-specific Recall Response In vitro and In vivo

Haas, S.

Management of Venous Thromboembolism in Routine Clinical Practice - Results from the Global GARFIELD-VTE Registry

Habbel, P.

GECAT - German Evaluation of Cancer associated Thrombosis: A Prospective Register Trial for Patients with Active Cancer and Venous Thromboembolism in Berlin

Häberle, H.

Acquired von Willebrand Syndrome during Mechanical Circulatory Support and Extracorporeal Membrane Oxygenation: Rapid Onset and the Demand for Point of Care Testing

Hackenbuchner, S.

Comparison of a New Prototype for Rapid Thawing of Fresh Frozen Plasma with Two Commercially Available Thawing Devices

Hahn, D.

Activity of Maleimide Functionalized Unfractionated and Low Molecular Weight Heparins

Haidl, H.

Elevated Bile Acid Levels Induce Tissue Factor Activity in Hepatocytes

Hainfellner, J.A.

Programmed Cell Death Ligand 1 and Venous Thromboembolism in Patients with Primary Brain Tumors

Halimeh, S.

Development of an Adherence Questionnaire for Haemophilia Patients of the German Health System

Thrombocytopenia Related to Defects in Platelet Cytoskeleton Regulation Genes

Interim Results of a Non-interventional Study on Efficacy and Tolerability of a VWF/FVIII Concentrate in von Willebrand's Disease

Assessment of Joint Health in Children with Haemophilia - Results of the German Energy Study

Establishment of Various Specific Parameters for the Routine Diagnostics in Patients with Glanzmann Thrombasthenia

Haemophilia A Prophylaxis with FVIII in Real-life: Snapshot Analysis on the Observational Study “Prevention of Bleeding in Haemophilia A by Prophylactic Treatment with Octanate^®, Wilate^® or Nuwiq^® - NIS Previq”

Halm-Heinrich, I.

Changes in Hemophilia Treatment in Eastern Germany in the Last Decade - A Survey from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)

Changes in Hemophilia Treatment in Eastern Germany in the Last Decade - A Survey from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)

Handgretinger, R.

Congenital Antithrombin Deficiency Type II: A Case Report

Handtke, S.

Heterogeneity in Agonist-induced Activation Responses and Thrombus Formation: Differences between Large and Small Platelets

Härdtner, C.

Platelet-leukocyte Complex Formation is Associated with, but Dispensable for Myocardial Ischemia Reperfusion Injury

Harenberg, J.

Study Design for Evaluating an In Vitrodiagnostic Test for Direct Oral Anticoagulants

Hartmann, J.

Responsiveness of PBMCs Isolated from Healthy Individuals towards rFVIII and rFVIIIFc

Identification of Plasma Cytokine Levels Correlating with FVIII Inhibitor Titer during ITI

Affinities of FVIII-specific IgG1 and IgG4 during ITI

Hartwich, O.

Cold Storage of Platelets in Additive Solution: The Impact of Residual Plasma in Apheresis Platelet Concentrates

Hasiba, B.

New Normal Ranges Measuring APC Resistance on a New Coagulation Analyzer (COAG360)

Hassel, J.

Plasma Levels of Soluble CLEC-2 in Patients with Different Solid Tumors

Heeb, S.R.

Anti-ADAMTS13 Autoantibody-specific Anti-idiotypic Antibodies Restore ADAMTS13 Activity in Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP) Patients

Anti-ADAMTS13 Autoantibody-specific Anti-idiotypic Antibodies Restore ADAMTS13 Activity in Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP) Patients

Heemskerk, J.W.M.

Heterogeneity in Agonist-induced Activation Responses and Thrombus Formation: Differences between Large and Small Platelets

Heidt, T.

Platelet-leukocyte Complex Formation is Associated with, but Dispensable for Myocardial Ischemia Reperfusion Injury

Heine, S.

Severe Thrombocytopenia and Platelet Granule Dysfunction Associated with the Combination of Novel Heterozygous Variants in TUBB1 and ITGB3

Heinzmann, D.

Phosphate-induced ORAI1 Expression and Store Operated Ca²⁺ Entry in Megakaryocytes

Hell, L.

Altered Protein Profiles in Platelets of Lupus Anticoagulant Positive Patients - New Players in LA-related Thrombosis?

Intraperitoneal Activation of Blood Coagulation via Tissue Factor Exposing Extracellular Vesicles in Patients with Liver Disease and Ascites

Programmed Cell Death Ligand 1 and Venous Thromboembolism in Patients with Primary Brain Tumors

Heller, C.

Baseline Data from a 24-month Prospective, Non-interventional, Multicentre Study in Germany to Evaluate the Real-world Usage and Effectiveness of rFVIIIFc and rFIXFc in Patients with Haemophilia A or B (PREVENT)

Identification of Plasma Cytokine Levels Correlating with FVIII Inhibitor Titer during ITI

Affinities of FVIII-specific IgG1 and IgG4 during ITI

Helmecke, T.

Activity of Maleimide Functionalized Unfractionated and Low Molecular Weight Heparins

Henkel-Klene, A.

Thermography as a Component of Telemedicine for Diagnosis, Therapy and Follow-up of Joint Bleeding, Soft-tissue Bleeding and Micro-bleeding

Hernandez-Salazar, B.

Hereditary Haemorrhagic Telangiectasia (HHT) as an Important Rare Haemorrhagic Disorder in Costa Rica - Report of Costa Rica

Hertfelder, H.J.

Severe Arterial Forearm Thrombosis in an 11-year-old Girl with Homozygous Antithrombin Deficiency typ IIb Budapest 3 and Mild Factor VII Deficiency Due to Homozygous Polymorphisms in the Factor 7 Gene and Antithrombotic Treatment

Hertfelder, H.-J.

Thrombocytopenia Related to Defects in Platelet Cytoskeleton Regulation Genes

Congenital Protein C Deficiency: Delayed Treatment of 14 Year Old Girl causes Prolonged Treatment, Several Complications and Unfavorable Results

Herzog, E.

Improving the FVIII Binding Affinity of a Recombinant VWF D'D3-albumin Fusion Molecule Translates to Dosing Benefits with Respect to the Half-life Extension of Co-administered FVIII

Hesse, G.

Thrombocytopenia Related to Defects in Platelet Cytoskeleton Regulation Genes

Hethershaw, E.

Calcium Binding to FXIII-A Subunit: Unique Characteristics

Hetjens, S.

Study Design for Evaluating an In Vitrodiagnostic Test for Direct Oral Anticoagulants

Hidiatov, O.

A New Method to Assess Platelet Activation and Leukocyte-platelet Aggregates in Whole Blood Samples by Flow Cytometry for Clinical Studies

Hilgendorf, I.

Platelet-leukocyte Complex Formation is Associated with, but Dispensable for Myocardial Ischemia Reperfusion Injury

Hill, A.

Results from a Phase 3, Multicenter, Noninferiority Study of Ravulizumab (ALXN1210) versus Eculizumab (ECU) in Adult Patients (pts) with Paroxysmal Nocturnal Hemoglubinuria (PNH) Naive to Complement Inhibitors (CI)

Hishamshah, Ibrahim Mohd

Results from a Phase 3, Randomized, Multicenter Study of Rurioctocog alfa Pegol PK-Guided Prophylaxis Targeting 2 FVIII Trough Levels in Patients with Severe Hemophilia a (Propel Study)

Hoening, K.

Determination of ɣ-carboxylation Pattern of Different Vitamin K Dependent Proteins with Respect to VKCFD1 Phenotype

Hoffmeister, C.

Von Willebrand factor (vWF) Impairs FVIII-containing Immune Complex Formation and Attenuates Murine FVIII-specific Recall Response In vitro and In vivo

Hohbein, A.

Protocol for Safe Management of Patients under DOAC Therapy before Cardiothoracic Surgery Compared to Patients Undergoing VKA or No Anticoagulation Therapy

Establishment of Various Specific Parameters for the Routine Diagnostics in Patients with Glanzmann Thrombasthenia

Platelet Complement C3α-chain Differs from Plasma C3α

Hohenstein, K.

Acquired von Willebrand Syndrome during Mechanical Circulatory Support and Extracorporeal Membrane Oxygenation: Rapid Onset and the Demand for Point of Care Testing

Hollerbach, A.

Sera of Syphilis Patients Contain Antiphospholipid Antibodies with Procoagulant Properties

Holstein, K.

Comparison of Electronic Documentation with Smart Medication^tm between 2014 and 2017

Bone Mineral Density and Bone Microstructure in Patients with Haemophilia in Northern Germany: Preliminary Findings of a Single Centre Study

LPS-induced Expression of Monocyte Tissue Factor (TF) Antigen Correlates with Markers of Systemic Inflammation in Patients with Hemophilia A and B

Treatment Pattern and Pain Related to Joint Bleeds and Non-joint Bleeds - real Life Data According to Electronic Diary Smart-medication^TM

Holzer, U.

Congenital Antithrombin Deficiency Type II: A Case Report

Holzhauer, S.

Changes in Hemophilia Treatment in Eastern Germany in the Last Decade - A Survey from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)

Diagnosis of ETV6-mutation Related Thrombocytopenia by Immunofluorescence Microscopy

Changes in Hemophilia Treatment in Eastern Germany in the Last Decade - A Survey from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)

Systematic Comparison of MRI and ultrasound scores to Assess Arthropathy in Children and Adolescents with Hemophilia

Hönes, J.

FibrinoQuick - A Rapid Fibrinogen Assay for Patient Blood Management

Hoppe, B.

Protein z Deficiency in Risk Pregnant Women

Hoppe, N.

Platelet-leukocyte Complex Formation is Associated with, but Dispensable for Myocardial Ischemia Reperfusion Injury

Horneff, S.

Prompt Response and Long Term Remission of Refractory MGUS Related Acquired Hemophilia with Bortezomib

Cancer Induced Hyperfibronolysis in a 59-year-old Woman with Congenital Hyperfibrinogenemia

Experience in the Treatment of Acquired Haemophilia A (AHA) in 26 Patients in Relation to Bleeding Control and Induction of Immune Tolerance

Hornung, V.

Determination of ɣ-carboxylation Pattern of Different Vitamin K Dependent Proteins with Respect to VKCFD1 Phenotype

Hrachovinova, I.

More severe ADAMTS13 Deficiency in Homozygous versus Compound Heterozygous Carriers of the ADAMTS13 c.4143_4144dupA Mutation in Congenital Thrombotic Thrombocytopenic Purpura (cTTP): Impact on Disease Onset?

Hudák, R.

The Thrombin Generation Test: A Research Method or a Diagnostic Test?

Huth-Kuhne, A.

Prophylaxis with Extended Dosing of BAY94-9027 Decreases Overall and Joint Bleeding Rates with Consistent Consumption for Over 4 Years of Treatment

Huth-Kühne, A.

Thrombocytopenia Related to Defects in Platelet Cytoskeleton Regulation Genes

Haemophilia A Prophylaxis with FVIII in Real-life: Snapshot Analysis on the Observational Study “Prevention of Bleeding in Haemophilia A by Prophylactic Treatment with Octanate^®, Wilate^® or Nuwiq^® - NIS Previq”

Iapichino, G.

Modified ROTEM^® xxtem Clotting Time Shows better Correlation with Endogenous Thrombin Potential than Standard Extem

Icheva, V.

Novel likely Pathogenic Variant in the Second Calcium Binding Domain of αIIb (Subunit of αIIbβ3) in a Patient with Glanzmann Thrombasthenia

Congenital Antithrombin Deficiency Type II: A Case Report

Imhof, D.

Calcium Binding to FXIII-A Subunit: Unique Characteristics

The FXIIIA₂B₂ Heterotetrameric Complex Structure: Unequal Pairing within a Symmetric Complex

Isermann, B.

Thrombomodulin Regulates Platelet and Extracellular Vesicle Mediated Sterile Inflammation in the Placenta

Thrombomodulin Regulates Platelet and Extracellular Vesicle Mediated Sterile Inflammation in the Placenta

Ivanova, E.

Reducing the Side Effects of Thrombolytic Agent by Regulating its Release Rate from Microcapsules

The Influence of Cationic Polyamidoamine Dendrimers on Key Components of Fibrinolysis and Coagulation Systems

Ivaskevicius, V.

Calcium Binding to FXIII-A Subunit: Unique Characteristics

The FXIIIA₂B₂ Heterotetrameric Complex Structure: Unequal Pairing within a Symmetric Complex

A Novel Missense Mutation in ITGB3 Gene Causing Autosomal Dominant Glanzmann Thrombasthenia

Jacak, J.

Plasmin-induced Alterations to Platelet GPIIb/IIIa Receptors Impair Secondary Blood Clot Firmness

Jahnel, J.

Elevated Bile Acid Levels Induce Tissue Factor Activity in Hepatocytes

Jainz, A.

Protein z Deficiency in Risk Pregnant Women

Jamil, M.A.

Methylation Profile of Adult and Fetal FVIII Secreting Endothelial Cells in Comparison to other Endothelial Cells

Jaschonek, K.

Acquired von Willebrand Syndrome during Mechanical Circulatory Support and Extracorporeal Membrane Oxygenation: Rapid Onset and the Demand for Point of Care Testing

Jerzy, Windyga

Results from a Phase 3, Randomized, Multicenter Study of Rurioctocog alfa Pegol PK-Guided Prophylaxis Targeting 2 FVIII Trough Levels in Patients with Severe Hemophilia a (Propel Study)

Jesse, P.

Systematic Comparison of MRI and ultrasound scores to Assess Arthropathy in Children and Adolescents with Hemophilia

Jilma, P.

Emicizumab for the Treatment of Acquired Hemophilia A: Lessons Learned from 4 very Different Cases

Jiménez-Yuste, V.

Emicizumab Prophylaxis Administered Once-weekly or Every Two Weeks Provides Effective Bleed Prevention in Persons with Hemophilia A (PwHA) without Inhibitors - Results from the Phase III HAVEN 3 Study

Emicizumab Prophylaxis Administered Once-weekly or Every Two Weeks Provides Effective Bleed Prevention in Persons with Hemophilia A (PwHA) without Inhibitors - Results from the Phase III HAVEN 3 Study

John, A.

The Endothelial Glycocalyx Contributes to the Anchorage of von Willebrand Factor Fibers to the Vascular Endothelium

Joshi, U.

Pancreatic Tumor Microvesicles Invade Immune Cells via CD36 and Distinctly Promote Tumor-associated Deep Vein Thrombosis

Jouni, R.

Glycan Changes on Platelet and Megakaryocyte: A Potential Impact on Platelet Function and Lifespan in Immune Thrombocytopenia

Anti-Glycoprotein V Autoantibodies in Patients with Immune Thrombocytopenia

A New Method to Assess Platelet Activation and Leukocyte-platelet Aggregates in Whole Blood Samples by Flow Cytometry for Clinical Studies

Cold Storage of Platelets in Additive Solution: The Impact of Residual Plasma in Apheresis Platelet Concentrates

Jühling, A.

GECAT - German Evaluation of Cancer associated Thrombosis: A Prospective Register Trial for Patients with Active Cancer and Venous Thromboembolism in Berlin

Jünger, M.

Thrombosis after Venous Surgery - Is a Postoperative Heparin Prophylaxis Indicated?

Jureta, M.

Eleven Relapses in a Cohort of 78 Patients with Immune Thrombotic Thrombocytopenic Purpura (iTTP): Data from the German TTP-Registry

Jurk, K.

Severe Thrombocytopenia and Platelet Granule Dysfunction Associated with the Combination of Novel Heterozygous Variants in TUBB1 and ITGB3

The Gut Microbiota Restricts NETosis in Mesenteric Ischemia-reperfusion Injury

The Direct Thrombin Inhibitors Dabigatran and Lepirudin Inhibit GPIbα-mediated Platelet Aggregation

The First THROMKID-Plus Inter-laboratory Survey - Standardization and Quality Management of Platelet Light Transmission Aggregometry for the Diagnosis of Inherited Platelet Function Disorders in German-speaking Countries

The First THROMKID-Plus Inter-laboratory Survey - standardization and Quality Management of Platelet Light Transmission Aggregometry for the Diagnosis of Inherited Platelet Function Disorders in German-speaking Countries

Eleven Relapses in a Cohort of 78 Patients with Immune Thrombotic Thrombocytopenic Purpura (iTTP): Data from the German TTP-Registry

Kadar, J.

Interim Results of a Non-interventional Study on Efficacy and Tolerability of a VWF/FVIII Concentrate in von Willebrand's Disease

Kaiser, N.

Congenital Antithrombin Deficiency Type II: A Case Report

Kakkar, A.K.

Management of Venous Thromboembolism in Routine Clinical Practice - Results from the Global GARFIELD-VTE Registry

Kalagara, T.

The Endothelial Glycocalyx Contributes to the Anchorage of von Willebrand Factor Fibers to the Vascular Endothelium

Kamphuisen, P.

Determinants of the Quality of Warfarin Control and Validation of the SAMe-TT2-R2 Score for Acute Venous Thromboembolism. An Analysis of the Hokusai-VTE Trial

Kanniyappan, S.

The FXIIIA₂B₂ Heterotetrameric Complex Structure: Unequal Pairing within a Symmetric Complex

Kaplunova, M.

New Oral Anticoagulants for Prevention of Complications of Venous Thromboembolism in Burn Patients

Hemorheological Parameters as Predictors of Venous Thromboembolism in Burned Patients

Venous Thromboembolism Risks Modeling in Burn Patients

Correlation between Indicators of Endogenous Vascular Regulation and System of Hemostasis in Burn Patients

Nanosilver Induce Platelet Pro-thrombotic Ability in Norm and Pathology

Diagnostic Coagulopathy in Burn Patients in the Acute Period of Thermal Injury

Kappelmayer, J.

Evaluation of the Analytical Performance of von Willebrand Factor Antigen and Activity Tests on the Cobas t511 Coagulation Analyser

The Thrombin Generation Test: A Research Method or a Diagnostic Test?

Kappert, G.

Assessment of Joint Health in Children with Haemophilia - Results of the German Energy Study

Establishment of Various Specific Parameters for the Routine Diagnostics in Patients with Glanzmann Thrombasthenia

Karastaneva, A.

Diagnosis of ETV6-mutation Related Thrombocytopenia by Immunofluorescence Microscopy

Karges, H.E.

Ultrastructure of the Fibrin Fibril Revealed by Electron Microscopical Investigations

Karkouti, K.

Fibrinogen Concentrate vs. Cryoprecipitate for Acquired Hypofibrinogenemia in cardIac Surgery - The FIBRES Study

Kausch, M.

Recurrent Pediatric Stroke: The Role of Thrombophilia in a Large International Pediatric Stroke Population

Recurrent Pediatric Stroke: The Role of Thrombophilia in a Large International Pediatric Stroke Population

Kaya, E.

Affinities of FVIII-specific IgG1 and IgG4 during ITI

Kayani, G.

Management of Venous Thromboembolism in Routine Clinical Practice - Results from the Global GARFIELD-VTE Registry

Kehrel, B.E.

Some Plasma Derived FVIII Concentrates Activated FXII Leading to Kallikrein and Bradykinin Formation In vitro, while Recombinant FVIII Concentrates did not

Keller, K.

Cost-effectiveness of a Telemedicine-based Coagulation Service versus Routine Medical Care for the Management of Patients Receiving Vitamin K-antagonists - Results from the thrombEVAL Study

Kemkes-Matthes, B.

Successful Control of Bleeding with Emicizumab in Aquired Haemophilia A: A Case Report

Direct Oral Anticoagulants in Patients with Antiphospholipid Syndrome: Results from a Retrospective Study in a Real-life Patient Cohort

Direct Oral Anticoagulants in Patients with Antiphospholipid Syndrome: Results from a Retrospective Study in a Real-life Patient Cohort

Kempton, C.

Emicizumab Prophylaxis Administered Once-weekly or Every Two Weeks Provides Effective Bleed Prevention in Persons with Hemophilia A (PwHA) without Inhibitors - Results from the Phase III HAVEN 3 Study

Emicizumab Prophylaxis Administered Once-weekly or Every Two Weeks Provides Effective Bleed Prevention in Persons with Hemophilia A (PwHA) without Inhibitors - Results from the Phase III HAVEN 3 Study

Kenet, G.

Recurrent Pediatric Stroke: The Role of Thrombophilia in a Large International Pediatric Stroke Population

Recurrent Pediatric Stroke: The Role of Thrombophilia in a Large International Pediatric Stroke Population

Kentouche, K.

Changes in Hemophilia Treatment in Eastern Germany in the Last Decade - A Survey from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)

GEPHARD - the PUP Cohort of the `Standing Commission Paediatrics of the Society for Thrombosis and Haemostasis Research´ - A Progress Report

Changes in Hemophilia Treatment in Eastern Germany in the Last Decade - A Survey from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)

Kerényi, A.

Evaluation of the Analytical Performance of von Willebrand Factor Antigen and Activity Tests on the Cobas t511 Coagulation Analyser

Ketter, R.

Glioblastoma Cell Adhesion and Invasion in Fibrin is Promoted through β₃ Integrin

Key, N.S.

Phase 2b Trial of AMT-061 (AAV5-Padua hFIX): Translation into Humans of an Enhanced Gene Transfer Vector for Adults with Severe or Moderate-severe Hemophilia B

HOPE-B: Study Design of a Phase III trial of an Investigational Gene Therapy AMT-061 in Subjects with Severe or Moderately Severe Hemophilia B

Khromina, S.

Hemorheological Parameters as Predictors of Venous Thromboembolism in Burned Patients

Nanosilver Induce Platelet Pro-thrombotic Ability in Norm and Pathology

Diagnostic Coagulopathy in Burn Patients in the Acute Period of Thermal Injury

Khvatov, V.

Hemorheological Parameters as Predictors of Venous Thromboembolism in Burned Patients

Kiesewetter, H.

Protein z Deficiency in Risk Pregnant Women

Treatment of High-risk Pregnancies with Tinzaparin

Kirkham, F.

Recurrent Pediatric Stroke: The Role of Thrombophilia in a Large International Pediatric Stroke Population

Recurrent Pediatric Stroke: The Role of Thrombophilia in a Large International Pediatric Stroke Population

Kirschfink, M.

Increased Permeability of Tumor Blood Vessels is Triggered by Membrane Attack Complex Activated Neutrophils

Kirsten, R.

Plasma Levels of Soluble CLEC-2 in Patients with Different Solid Tumors

Kistner, S.

Coagulation Factor VIII with Reduced Immunogenicity via a Direct De-immunization Approach

Kjaer, M.

In vitro and In vivo Validation of a Laboratory Assay for Monitoring Survival of Transfused Platelets: Tracking HLA Mismatch between Donor and Recipient

Kjeldsen-Kragh, J.

In vitro and In vivo Validation of a Laboratory Assay for Monitoring Survival of Transfused Platelets: Tracking HLA Mismatch between Donor and Recipient

Klamroth, R.

Successful Immune Tolerance Induction in Two Patients with Severe Haemophilia B with Inhibitors and Anaphylaxis

Comparison of Electronic Documentation with Smart Medication^tm between 2014 and 2017

Changes in Hemophilia Treatment in Eastern Germany in the Last Decade - A Survey from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)

GECAT - German Evaluation of Cancer associated Thrombosis: A Prospective Register Trial for Patients with Active Cancer and Venous Thromboembolism in Berlin

Changes in Hemophilia Treatment in Eastern Germany in the Last Decade - A Survey from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)

Systematic Comparison of MRI and ultrasound scores to Assess Arthropathy in Children and Adolescents with Hemophilia

Treatment Pattern and Pain Related to Joint Bleeds and Non-joint Bleeds - real Life Data According to Electronic Diary Smart-medication^TM

Haemophilia A Prophylaxis with FVIII in Real-life: Snapshot Analysis on the Observational Study “Prevention of Bleeding in Haemophilia A by Prophylactic Treatment with Octanate^®, Wilate^® or Nuwiq^® - NIS Previq”

Kleikamp, A.

Protocol for Safe Management of Patients under DOAC Therapy before Cardiothoracic Surgery Compared to Patients Undergoing VKA or No Anticoagulation Therapy

Klein, C.

Prompt Response and Long Term Remission of Refractory MGUS Related Acquired Hemophilia with Bortezomib

Cancer Induced Hyperfibronolysis in a 59-year-old Woman with Congenital Hyperfibrinogenemia

Experience in the Treatment of Acquired Haemophilia A (AHA) in 26 Patients in Relation to Bleeding Control and Induction of Immune Tolerance

Klingebiel, T.

Identification of Plasma Cytokine Levels Correlating with FVIII Inhibitor Titer during ITI

Affinities of FVIII-specific IgG1 and IgG4 during ITI

Klopocki, E.

Use of Targeted High-throughput Sequencing for Genetic Classification of Patients with Bleeding Diathesis and Suspected Platelet Disorder

Use of Targeted High-throughput Sequencing for Genetic Classification of Patients with Bleeding Diathesis and Suspected Platelet Disorder

Kluge, S.

A Laboratory Approach to Standardize Luminoaggregometry for Sample Shipment

Klychnikova, E.

New Oral Anticoagulants for Prevention of Complications of Venous Thromboembolism in Burn Patients

Correlation between Indicators of Endogenous Vascular Regulation and System of Hemostasis in Burn Patients

Diagnostic Coagulopathy in Burn Patients in the Acute Period of Thermal Injury

Knabbe, C.

Protocol for Safe Management of Patients under DOAC Therapy before Cardiothoracic Surgery Compared to Patients Undergoing VKA or No Anticoagulation Therapy

Establishment of Various Specific Parameters for the Routine Diagnostics in Patients with Glanzmann Thrombasthenia

Platelet Complement C3α-chain Differs from Plasma C3α

Knaub, S.

Efficacy and Safety of Fibrinogen Concentrate for On-demand Treatment of Acute Bleeding and for Surgical Prophylaxis in Subjects with Congenital Fibrinogen Deficiency - A Phase 3 Study

Fibrinogen Concentrate vs Cryoprecipitate in Pseudomyxoma Peritonei Surgery: Interim Results from a Prospective, Randomized, Controlled Phase 2 Study

Knöbl, P.N.

More severe ADAMTS13 Deficiency in Homozygous versus Compound Heterozygous Carriers of the ADAMTS13 c.4143_4144dupA Mutation in Congenital Thrombotic Thrombocytopenic Purpura (cTTP): Impact on Disease Onset?

Knoebl, P.

Emicizumab for the Treatment of Acquired Hemophilia A: Lessons Learned from 4 very Different Cases

Safety Results Normalized to Time of Exposure during the Phase 3 HERCULES Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura

Risk Factors and Manageability of the Mucocutaneous Bleeding Profile Observed in aTTP Patients Treated with Caplacizumab during the Phase III HERCULES Study

Safety Results Normalized to Time of Exposure during the Phase 3 HERCULES Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura

Knöfler, R.

Changes in Hemophilia Treatment in Eastern Germany in the Last Decade - A Survey from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)

Changes in Hemophilia Treatment in Eastern Germany in the Last Decade - A Survey from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)

Knowles, L.M.

Glioblastoma Cell Adhesion and Invasion in Fibrin is Promoted through β₃ Integrin

Knüttgen, F.

Protocol for Safe Management of Patients under DOAC Therapy before Cardiothoracic Surgery Compared to Patients Undergoing VKA or No Anticoagulation Therapy

Establishment of Various Specific Parameters for the Routine Diagnostics in Patients with Glanzmann Thrombasthenia

Platelet Complement C3α-chain Differs from Plasma C3α

Kobayashi, T.

Risk of Venous and Arterial Thromboembolism among Japanese Users of Oral Contraceptives

Koch, K.

A Universal Anti-Xa Assay for the Determination of Rivaroxaban and Apixaban Plasma Concentrations: An In vitro Investigation and Evaluation Study in Real-life Clinical Practice

Koder, S.

Altered Protein Profiles in Platelets of Lupus Anticoagulant Positive Patients - New Players in LA-related Thrombosis?

Emicizumab for the Treatment of Acquired Hemophilia A: Lessons Learned from 4 very Different Cases

Kohli, S.

Thrombomodulin Regulates Platelet and Extracellular Vesicle Mediated Sterile Inflammation in the Placenta

Thrombomodulin Regulates Platelet and Extracellular Vesicle Mediated Sterile Inflammation in the Placenta

Kolde, H.-J.

A New Rapid, Specific, and Simple ELISA for von Willebrand Factor Propeptide

Köngs, C.

Successful Immune Tolerance Induction in Two Patients with Severe Haemophilia B with Inhibitors and Anaphylaxis

König, E.-M.

Use of Targeted High-throughput Sequencing for Genetic Classification of Patients with Bleeding Diathesis and Suspected Platelet Disorder

Use of Targeted High-throughput Sequencing for Genetic Classification of Patients with Bleeding Diathesis and Suspected Platelet Disorder

König, G.

Investigation of VWD Type 2B Variants by Light Transmission Aggregometry

Königs, C.

Responsiveness of PBMCs Isolated from Healthy Individuals towards rFVIII and rFVIIIFc

The Evolution of Antibody Response during Immune Tolerance INDUCTION IN PAtients with Severe Hemophilia A Predicts Outcome

GEPHARD - the PUP Cohort of the `Standing Commission Paediatrics of the Society for Thrombosis and Haemostasis Research´ - A Progress Report

Identification of Plasma Cytokine Levels Correlating with FVIII Inhibitor Titer during ITI

Affinities of FVIII-specific IgG1 and IgG4 during ITI

Vaccination in Patients with Hemophilia - Results from an Online Survey among German Haemostaseologists

Königsbrügge, O.

Citrullinated Histone H3, a Biomarker for Neutrophil Extracellular Trap Formation, Predicts the Risk of Mortality in Patients with Cancer

Korczowski, B.

Long-term Efficacy and Safety of rVIII-SingleChain in Patients with Severe Hemophilia A: Interim Results of an Extension Study

Korsholm, L.

Safety and Efficacy of Turoctocog Alfa in Severe and Moderately Severe Previously Treated Patients with Haemophilia A: Interim Results after >4,000 Exposure Days (Guardian 5)

Koscielny, J.

Changes in Hemophilia Treatment in Eastern Germany in the Last Decade - A Survey from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)

Interim Results of a Non-interventional Study on Efficacy and Tolerability of a VWF/FVIII Concentrate in von Willebrand's Disease

Changes in Hemophilia Treatment in Eastern Germany in the Last Decade - A Survey from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)

Kowalski, D.

Role of Gender and ABO-blood Group in White Adolescents and Young Adult Patients with First VTE Onset

Kragh, T.

Functional Characterisation of a von Willebrand Factor Concentrate with Low Factor VIII Content - Multimeric and Flow Chamber Analysis and a Case Report

Krammer-Steiner, B.

Changes in Hemophilia Treatment in Eastern Germany in the Last Decade - A Survey from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)

A New Rapid, Specific, and Simple ELISA for von Willebrand Factor Propeptide

Changes in Hemophilia Treatment in Eastern Germany in the Last Decade - A Survey from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)

Kraus, M.-J.

Establishment of Various Specific Parameters for the Routine Diagnostics in Patients with Glanzmann Thrombasthenia

Krause, D.S.

EPCR Raft Signaling Controls Activity of Hematopoietic Progenitor and Stem Cells

Krause, M.

Severe Thrombocytopenia and Platelet Granule Dysfunction Associated with the Combination of Novel Heterozygous Variants in TUBB1 and ITGB3

Measurement of Thrombophilic Profile under Removing DOACs from Plasma Samples

Vaccination in Patients with Hemophilia - Results from an Online Survey among German Haemostaseologists

Kreibisch, U.

Changes in Hemophilia Treatment in Eastern Germany in the Last Decade - A Survey from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)

Changes in Hemophilia Treatment in Eastern Germany in the Last Decade - A Survey from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)

Kremer, J. Hovinga

Detection and Differential Diagnosis of Prekallikrein Deficiency: Genetic Study of New Families and Systematic Review of the Literature

Kremer, J.A. Hovinga

Safety Results Normalized to Time of Exposure during the Phase 3 HERCULES Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura

Anti-ADAMTS13 Autoantibody-specific Anti-idiotypic Antibodies Restore ADAMTS13 Activity in Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP) Patients

Risk Factors and Manageability of the Mucocutaneous Bleeding Profile Observed in aTTP Patients Treated with Caplacizumab during the Phase III HERCULES Study

Safety Results Normalized to Time of Exposure during the Phase 3 HERCULES Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura

Anti-ADAMTS13 Autoantibody-specific Anti-idiotypic Antibodies Restore ADAMTS13 Activity in Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP) Patients

More severe ADAMTS13 Deficiency in Homozygous versus Compound Heterozygous Carriers of the ADAMTS13 c.4143_4144dupA Mutation in Congenital Thrombotic Thrombocytopenic Purpura (cTTP): Impact on Disease Onset?

Kroening, P.

The Inflammatory Landscape during Myocardial Reperfusion Injury Depends on Distinct Neutrophil Phenotypes

Kröning, P.

Platelet Serotonin in Arterial and Deep Vein Thrombosis

Kruse-Jarres, R.

Emicizumab Prophylaxis Administered Once-weekly or Every Two Weeks Provides Effective Bleed Prevention in Persons with Hemophilia A (PwHA) without Inhibitors - Results from the Phase III HAVEN 3 Study

Emicizumab Prophylaxis Administered Once-weekly or Every Two Weeks Provides Effective Bleed Prevention in Persons with Hemophilia A (PwHA) without Inhibitors - Results from the Phase III HAVEN 3 Study

Krutzinna, M.

Protocol for Safe Management of Patients under DOAC Therapy before Cardiothoracic Surgery Compared to Patients Undergoing VKA or No Anticoagulation Therapy

Kruzhkova, I.

Fibrinogen Concentrate vs Cryoprecipitate in Pseudomyxoma Peritonei Surgery: Interim Results from a Prospective, Randomized, Controlled Phase 2 Study

Kubicek-Hofmann, C.

Successful Immune Tolerance Induction in Two Patients with Severe Haemophilia B with Inhibitors and Anaphylaxis

Kuhn, J.

Protocol for Safe Management of Patients under DOAC Therapy before Cardiothoracic Surgery Compared to Patients Undergoing VKA or No Anticoagulation Therapy

Kurnik, K.

GEPHARD - the PUP Cohort of the `Standing Commission Paediatrics of the Society for Thrombosis and Haemostasis Research´ - A Progress Report

Switching to rVIII-SingleChain Ensures Bleeding Protection and may Reduce Injection Frequency or Consumption in Hemophilia A Patients: Real-world Clinical Experience in Adults/Adolescents and Pediatric Patients

Kuznietsova, H.

Subacute Megakaryocytopoietic Toxicity of Maleimide Derivative with Antitumor Activity

Kyrle, P.A.

Risk and Determinants of Provoked Recurrent Venous Thromboembolism: A Prospective Cohort Study

Lackner, K.

Severe Thrombocytopenia and Platelet Granule Dysfunction Associated with the Combination of Novel Heterozygous Variants in TUBB1 and ITGB3

Detection and Differential Diagnosis of Prekallikrein Deficiency: Genetic Study of New Families and Systematic Review of the Literature

Sera of Syphilis Patients Contain Antiphospholipid Antibodies with Procoagulant Properties

Lackner, K.J.

The Gut Microbiota Restricts NETosis in Mesenteric Ischemia-reperfusion Injury

The Relation between Coagulant and Vascular Function in Adult Survivors of Childhood Cancer

Lämmerhofer, M.

Platelet Lipidome and Lipid Induced Thromboinflammatory Actions are Influenced by the CXCL12-CXCR4-CXCR7 Axis

Platelet Lipidome and Lipid Induced Thromboinflammatory Actions are Influenced by the CXCL12-CXCR4-CXCR7 Axis

Lämmle, B.

Detection and Differential Diagnosis of Prekallikrein Deficiency: Genetic Study of New Families and Systematic Review of the Literature

More severe ADAMTS13 Deficiency in Homozygous versus Compound Heterozygous Carriers of the ADAMTS13 c.4143_4144dupA Mutation in Congenital Thrombotic Thrombocytopenic Purpura (cTTP): Impact on Disease Onset?

Eleven Relapses in a Cohort of 78 Patients with Immune Thrombotic Thrombocytopenic Purpura (iTTP): Data from the German TTP-Registry

Lang, F.

Phosphate-induced ORAI1 Expression and Store Operated Ca²⁺ Entry in Megakaryocytes

Lang, I.M.

Citrullinated Histone H3, a Biomarker for Neutrophil Extracellular Trap Formation, Predicts the Risk of Mortality in Patients with Cancer

Lang, T.

Interim Results of a Non-interventional Study on Efficacy and Tolerability of a VWF/FVIII Concentrate in von Willebrand's Disease

Langer, F.

Baseline Data from a 24-month Prospective, Non-interventional, Multicentre Study in Germany to Evaluate the Real-world Usage and Effectiveness of rFVIIIFc and rFIXFc in Patients with Haemophilia A or B (PREVENT)

Bone Mineral Density and Bone Microstructure in Patients with Haemophilia in Northern Germany: Preliminary Findings of a Single Centre Study

LPS-induced Expression of Monocyte Tissue Factor (TF) Antigen Correlates with Markers of Systemic Inflammation in Patients with Hemophilia A and B

Myeloperoxidase (MPO) Inhibits the Procoagulant Activity (PCA) of Extracellular DNA

Lasch, M.

Inflammatory Function of Ribosomal RNA-containing Microvesicles from Mast Cells

Lattimore, S.

Phase 2b Trial of AMT-061 (AAV5-Padua hFIX): Translation into Humans of an Enhanced Gene Transfer Vector for Adults with Severe or Moderate-severe Hemophilia B

HOPE-B: Study Design of a Phase III trial of an Investigational Gene Therapy AMT-061 in Subjects with Severe or Moderately Severe Hemophilia B

Lauterbach, M.

Cost-effectiveness of a Telemedicine-based Coagulation Service versus Routine Medical Care for the Management of Patients Receiving Vitamin K-antagonists - Results from the thrombEVAL Study

Lazareva, E.

The Kinetics of Platelet-derived Microparticles in Patients with ST Segment Elevation Acute Myocardial Infarction under Pharmacological Suppression of Platelet Aggregation

Lazarus, A.H.

Anti-Glycoprotein V Autoantibodies in Patients with Immune Thrombocytopenia

Lee, J.W.

Results from a Phase 3, Multicenter, Noninferiority Study of Ravulizumab (ALXN1210) versus Eculizumab (ECU) in Adult Patients (pts) with Paroxysmal Nocturnal Hemoglubinuria (PNH) Naive to Complement Inhibitors (CI)

Lee, L.W. Lee

Results from a Phase 3, Multicenter, Noninferiority Study of Ravulizumab (ALXN1210) versus Eculizumab (ECU) in Adult Patients (pts) with Paroxysmal Nocturnal Hemoglubinuria (PNH) Naive to Complement Inhibitors (CI)

Leebeek, F.G.

HOPE-B: Study Design of a Phase III trial of an Investigational Gene Therapy AMT-061 in Subjects with Severe or Moderately Severe Hemophilia B

Leebeek, F.W.G.

Phase 2b Trial of AMT-061 (AAV5-Padua hFIX): Translation into Humans of an Enhanced Gene Transfer Vector for Adults with Severe or Moderate-severe Hemophilia B

Lehmann, K.

Investigation of VWD Type 2B Variants by Light Transmission Aggregometry

Lehr, C.

LPS-induced Expression of Monocyte Tissue Factor (TF) Antigen Correlates with Markers of Systemic Inflammation in Patients with Hemophilia A and B

Leimkühler, K.

Comparison of a New Prototype for Rapid Thawing of Fresh Frozen Plasma with Two Commercially Available Thawing Devices

Leiva-Gabriel, K.

Hereditary Haemorrhagic Telangiectasia (HHT) as an Important Rare Haemorrhagic Disorder in Costa Rica - Report of Costa Rica

Leng, C.

GECAT - German Evaluation of Cancer associated Thrombosis: A Prospective Register Trial for Patients with Active Cancer and Venous Thromboembolism in Berlin

Levy, G.G.

Emicizumab Prophylaxis Administered Once-weekly or Every Two Weeks Provides Effective Bleed Prevention in Persons with Hemophilia A (PwHA) without Inhibitors - Results from the Phase III HAVEN 3 Study

Emicizumab Prophylaxis Administered Once-weekly or Every Two Weeks Provides Effective Bleed Prevention in Persons with Hemophilia A (PwHA) without Inhibitors - Results from the Phase III HAVEN 3 Study

Li, Y.

Long-term Efficacy and Safety of rVIII-SingleChain in Patients with Severe Hemophilia A: Interim Results of an Extension Study

Long-term Safety and Efficacy of rIX-FP in Patients with Hemophilia B: Intermediate Results from a Phase IIIb Extension Study

Liebscher, K.

Thrombocytopenia Related to Defects in Platelet Cytoskeleton Regulation Genes

Limperger, V.

Role of Gender and ABO-blood Group in White Adolescents and Young Adult Patients with First VTE Onset

Lin, M.

Determinants of the Quality of Warfarin Control and Validation of the SAMe-TT2-R2 Score for Acute Venous Thromboembolism. An Analysis of the Hokusai-VTE Trial

Lisman, T.

Intraperitoneal Activation of Blood Coagulation via Tissue Factor Exposing Extracellular Vesicles in Patients with Liver Disease and Ascites

Liu, T.

Prophylaxis with Extended Dosing of BAY94-9027 Decreases Overall and Joint Bleeding Rates with Consistent Consumption for Over 4 Years of Treatment

Liu, X.

Increased Permeability of Tumor Blood Vessels is Triggered by Membrane Attack Complex Activated Neutrophils

Lochmann, F.

Thrombomodulin Regulates Platelet and Extracellular Vesicle Mediated Sterile Inflammation in the Placenta

Thrombomodulin Regulates Platelet and Extracellular Vesicle Mediated Sterile Inflammation in the Placenta

Loewecke, F.

Successful Treatment with Emicizumab of a Patient with Severe Haemophilia A and Factor VIII Inhibitors

Lohr, B.

Severe Arterial Forearm Thrombosis in an 11-year-old Girl with Homozygous Antithrombin Deficiency typ IIb Budapest 3 and Mild Factor VII Deficiency Due to Homozygous Polymorphisms in the Factor 7 Gene and Antithrombotic Treatment

Lopez, M.

Measurement of Platelet's Count in different Anticoagulants should be Performed in Each Routine Blood Test

Lowe, F.

Effects of WSCM, eVCM and Nicotine on monocyte adhesion to human aortic endothelial cells

Lucas, S.

Long-term Efficacy and Safety of rVIII-SingleChain in Patients with Severe Hemophilia A: Interim Results of an Extension Study

Efficacy and Safety of rVIII-SingleChain in Controlling Surgical Hemostasis

Lüdemann, J.

A New Rapid, Specific, and Simple ELISA for von Willebrand Factor Propeptide

Ludolph, P.

Cost-effectiveness of a Telemedicine-based Coagulation Service versus Routine Medical Care for the Management of Patients Receiving Vitamin K-antagonists - Results from the thrombEVAL Study

Luis, A.

Plasmin-induced Alterations to Platelet GPIIb/IIIa Receptors Impair Secondary Blood Clot Firmness

Lurger, K.

Altered Protein Profiles in Platelets of Lupus Anticoagulant Positive Patients - New Players in LA-related Thrombosis?

Luxembourg, B.

Direct Oral Anticoagulants in Patients with Antiphospholipid Syndrome: Results from a Retrospective Study in a Real-life Patient Cohort

Direct Oral Anticoagulants in Patients with Antiphospholipid Syndrome: Results from a Retrospective Study in a Real-life Patient Cohort

Maas, M. Enriquez

Prophylaxis with Extended Dosing of BAY94-9027 Decreases Overall and Joint Bleeding Rates with Consistent Consumption for Over 4 Years of Treatment

Machesky, L.

Platelet Lamellipodia Formation is not Required for Thrombus Formation and Stability

Platelet Lamellipodia Formation is not Required for Thrombus Formation and Stability

Maghout, T.a.-

Phosphate-induced ORAI1 Expression and Store Operated Ca²⁺ Entry in Megakaryocytes

Mahlangu, J.

Emicizumab Prophylaxis Administered Once-weekly or Every Two Weeks Provides Effective Bleed Prevention in Persons with Hemophilia A (PwHA) without Inhibitors - Results from the Phase III HAVEN 3 Study

Emicizumab Prophylaxis Administered Once-weekly or Every Two Weeks Provides Effective Bleed Prevention in Persons with Hemophilia A (PwHA) without Inhibitors - Results from the Phase III HAVEN 3 Study

Long-term Efficacy and Safety of rVIII-SingleChain in Patients with Severe Hemophilia A: Interim Results of an Extension Study

Efficacy and Safety of rVIII-SingleChain in Controlling Surgical Hemostasis

Mahn, R.

Changes in Hemophilia Treatment in Eastern Germany in the Last Decade - A Survey from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)

Changes in Hemophilia Treatment in Eastern Germany in the Last Decade - A Survey from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)

Maitz, M.F.

Activity of Maleimide Functionalized Unfractionated and Low Molecular Weight Heparins

Makarov, M.

Nanosilver Induce Platelet Pro-thrombotic Ability in Norm and Pathology

Makhoul, S.

The Direct Thrombin Inhibitors Dabigatran and Lepirudin Inhibit GPIbα-mediated Platelet Aggregation

Makwana, O.

Effects of WSCM, eVCM and Nicotine on monocyte adhesion to human aortic endothelial cells

Malinova, L.

The Kinetics of Platelet-derived Microparticles in Patients with ST Segment Elevation Acute Myocardial Infarction under Pharmacological Suppression of Platelet Aggregation

Mancuso, M.E.

Emicizumab Prophylaxis Administered Once-weekly or Every Two Weeks Provides Effective Bleed Prevention in Persons with Hemophilia A (PwHA) without Inhibitors - Results from the Phase III HAVEN 3 Study

Emicizumab Prophylaxis Administered Once-weekly or Every Two Weeks Provides Effective Bleed Prevention in Persons with Hemophilia A (PwHA) without Inhibitors - Results from the Phase III HAVEN 3 Study

Mandl, A.

Comparison of a New Prototype for Rapid Thawing of Fresh Frozen Plasma with Two Commercially Available Thawing Devices

Mandorfer, M.

Intraperitoneal Activation of Blood Coagulation via Tissue Factor Exposing Extracellular Vesicles in Patients with Liver Disease and Ascites

Mansouri, B. Taleghani

Immunoadsorption for the Treatment of Acquired Haemophilia: A Systematic Review

Marini, I.

Glycan Changes on Platelet and Megakaryocyte: A Potential Impact on Platelet Function and Lifespan in Immune Thrombocytopenia

Phosphate-induced ORAI1 Expression and Store Operated Ca²⁺ Entry in Megakaryocytes

Anti-Glycoprotein V Autoantibodies in Patients with Immune Thrombocytopenia

A New Method to Assess Platelet Activation and Leukocyte-platelet Aggregates in Whole Blood Samples by Flow Cytometry for Clinical Studies

Cold Storage of Platelets in Additive Solution: The Impact of Residual Plasma in Apheresis Platelet Concentrates

Markmeyer, P.

Thrombomodulin Regulates Platelet and Extracellular Vesicle Mediated Sterile Inflammation in the Placenta

Thrombomodulin Regulates Platelet and Extracellular Vesicle Mediated Sterile Inflammation in the Placenta

Marosi, C.

Programmed Cell Death Ligand 1 and Venous Thromboembolism in Patients with Primary Brain Tumors

Marquardt, N.

Prompt Response and Long Term Remission of Refractory MGUS Related Acquired Hemophilia with Bortezomib

Haemophilia and Osteoporosis Management in Germany

Cancer Induced Hyperfibronolysis in a 59-year-old Woman with Congenital Hyperfibrinogenemia

Experience in the Treatment of Acquired Haemophilia A (AHA) in 26 Patients in Relation to Bleeding Control and Induction of Immune Tolerance

Marten, S.

NOAC Therapy is also Effective and Safe in Patients Older than 80 Years - Results of the Prospective Dresden NOAC Registry (NCT01588119)

Treatment of VTE with Rivaroxaban in Adolescents - Preliminary Findings from the Prospective Dresden NOAC Registry (NCT01588119)

Martin, W.

Coagulation Factor VIII with Reduced Immunogenicity via a Direct De-immunization Approach

Massberg, S.

Pancreatic Tumor Microvesicles Invade Immune Cells via CD36 and Distinctly Promote Tumor-associated Deep Vein Thrombosis

Matsumoto, M.

More severe ADAMTS13 Deficiency in Homozygous versus Compound Heterozygous Carriers of the ADAMTS13 c.4143_4144dupA Mutation in Congenital Thrombotic Thrombocytopenic Purpura (cTTP): Impact on Disease Onset?

Matsushita, T.

Systematic Review of Efficacy of Recombinant Factor IX Products for Prophylactic Treatment of Hemophilia B

Matysiak, A.

Bone Mineral Density and Bone Microstructure in Patients with Haemophilia in Northern Germany: Preliminary Findings of a Single Centre Study

LPS-induced Expression of Monocyte Tissue Factor (TF) Antigen Correlates with Markers of Systemic Inflammation in Patients with Hemophilia A and B

Matytsina, I.

Safety and Efficacy of Turoctocog Alfa in Severe and Moderately Severe Previously Treated Patients with Haemophilia A: Interim Results after >4,000 Exposure Days (Guardian 5)

Mauler, M.

The Inflammatory Landscape during Myocardial Reperfusion Injury Depends on Distinct Neutrophil Phenotypes

Platelet-leukocyte Complex Formation is Associated with, but Dispensable for Myocardial Ischemia Reperfusion Injury

Platelet Serotonin in Arterial and Deep Vein Thrombosis

Mauracher, L.M.

Citrullinated Histone H3, a Biomarker for Neutrophil Extracellular Trap Formation, Predicts the Risk of Mortality in Patients with Cancer

Mauracher, L.-M.

Altered Protein Profiles in Platelets of Lupus Anticoagulant Positive Patients - New Players in LA-related Thrombosis?

Mayer, F.T.

Platelet-derived von Willebrand Factor Fosters Intracranial Hypercoagulation in Metastatic Brains of Mice and Humans

Mayr, S.

Plasmin-induced Alterations to Platelet GPIIb/IIIa Receptors Impair Secondary Blood Clot Firmness

Mázló, A.

Evaluation of the Analytical Performance of von Willebrand Factor Antigen and Activity Tests on the Cobas t511 Coagulation Analyser

McKeand, W.

Population Pharmacokinetic Analysis of Recombinant Fusion Protein Linking Coagulation Factor IX with Recombinant Albumin (rIX-FP) in Adult and Pediatric Patients with Severe Hemophilia B

Medvidov, M.

Single-molecule Labeling and Tracking of FcγRIIA on Human Platelets Reveals Differential Mobility Dynamics, which Depends on Platelet Cytoskeletal Integrity

Single-molecule Labeling and Tracking of FcγRIIA on Human Platelets Reveals Differential Mobility Dynamics, which Depends on Platelet Cytoskeletal Integrity

Megens, R.T.A.

Pancreatic Tumor Microvesicles Invade Immune Cells via CD36 and Distinctly Promote Tumor-associated Deep Vein Thrombosis

Meinel, K.

Elevated Bile Acid Levels Induce Tissue Factor Activity in Hepatocytes

Mekawy, M.

Assessment of the Added Value of Combined Measurement of Immature Platelet Fraction and Schistocyte Count to Differentiate between Pregnancy-associated Thrombotic Thrombocytopenic Purpura and SPE/HELLP Syndrome

Menne, J.

Incidence of Acquired Thrombotic Thrombocytopenic Purpura Episodes in adults in Germany: Results of a Hospital Level Study and Projection to National Estimates

Merzenich, H.

The Relation between Coagulant and Vascular Function in Adult Survivors of Childhood Cancer

Metjian, A.

Safety Results Normalized to Time of Exposure during the Phase 3 HERCULES Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura

Risk Factors and Manageability of the Mucocutaneous Bleeding Profile Observed in aTTP Patients Treated with Caplacizumab during the Phase III HERCULES Study

Safety Results Normalized to Time of Exposure during the Phase 3 HERCULES Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura

Miesbach, W.

Baseline Data from a 24-month Prospective, Non-interventional, Multicentre Study in Germany to Evaluate the Real-world Usage and Effectiveness of rFVIIIFc and rFIXFc in Patients with Haemophilia A or B (PREVENT)

Phase 2b Trial of AMT-061 (AAV5-Padua hFIX): Translation into Humans of an Enhanced Gene Transfer Vector for Adults with Severe or Moderate-severe Hemophilia B

Incidence of Acquired Thrombotic Thrombocytopenic Purpura Episodes in adults in Germany: Results of a Hospital Level Study and Projection to National Estimates

HOPE-B: Study Design of a Phase III trial of an Investigational Gene Therapy AMT-061 in Subjects with Severe or Moderately Severe Hemophilia B

Miloni, E.

Detection and Differential Diagnosis of Prekallikrein Deficiency: Genetic Study of New Families and Systematic Review of the Literature

Minkue, J.

Safety Results Normalized to Time of Exposure during the Phase 3 HERCULES Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura

Risk Factors and Manageability of the Mucocutaneous Bleeding Profile Observed in aTTP Patients Treated with Caplacizumab during the Phase III HERCULES Study

Safety Results Normalized to Time of Exposure during the Phase 3 HERCULES Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura

Mir, P. Seyed Nazari

Programmed Cell Death Ligand 1 and Venous Thromboembolism in Patients with Primary Brain Tumors

Mirasol, A.

Development of Deep Vein Thrombosis after Achieving Remission in a Patient with Acquired Hemophilia A

Mischnik, M.

Improving the FVIII Binding Affinity of a Recombinant VWF D'D3-albumin Fusion Molecule Translates to Dosing Benefits with Respect to the Half-life Extension of Co-administered FVIII

Moerschbacher, B.M.

The Endothelial Glycocalyx Contributes to the Anchorage of von Willebrand Factor Fibers to the Vascular Endothelium

Mohamed, F.

Fibrinogen Concentrate vs Cryoprecipitate in Pseudomyxoma Peritonei Surgery: Interim Results from a Prospective, Randomized, Controlled Phase 2 Study

Mondorf, W.

Comparison of Electronic Documentation with Smart Medication^tm between 2014 and 2017

Smart Medication™ ITP - Feasibility of Online Surveillance in Patients with Immunthrombocytopenia

Smart medication^tm - A Pilot Study for Investigating the Feasibility of Speech Recognition of Natural Language to Access Electronic Patient Diary

Impact of GDPR (DSGVO) on Smart Medication™ Electronic Patient Diary

Treatment Pattern and Pain Related to Joint Bleeds and Non-joint Bleeds - real Life Data According to Electronic Diary Smart-medication^TM

Moog, R.

Quality of Plasma Collected with Closed Plasmapheresis Disposables

Moore, R.

Assessment of Joint Health in Children with Haemophilia - Results of the German Energy Study

Moser, O.

Plasma-derived Factor X Therapy for Treatment of Intracranial Bleeding in a Patient with Factor X Deficiency: A Case Report

Moutsis, T.

The Endothelial Glycocalyx Contributes to the Anchorage of von Willebrand Factor Fibers to the Vascular Endothelium

Muhr, T.

Ticagrelor Inhibits the Functional Assay for Heparin-induced Thrombocytopenia

Mukhametova, L.

Reducing the Side Effects of Thrombolytic Agent by Regulating its Release Rate from Microcapsules

The Influence of Cationic Polyamidoamine Dendrimers on Key Components of Fibrinolysis and Coagulation Systems

Müllejans, P.

Haemophilia and Osteoporosis Management in Germany

Müller, J.

Determination of ɣ-carboxylation Pattern of Different Vitamin K Dependent Proteins with Respect to VKCFD1 Phenotype

The Activated Protein C (APC) Response to In vivo Thrombin Formation Correlates with the Thrombotic Risk in Factor V Leiden but not in Prothrombin G20210A Carriers

Using an Oligonucleotide-based Enzyme Capture Assay and Physiological Activation by the Thrombin-Thrombomodulin Complex Improves Protein C Deficiency Testing

Monitoring of Emicizumab using a Two-stage chromogenic tenase platform: assay Development and Validation

Flow Cytometric Quantification of Human Platelet Membrane Glycoproteins in Citrated Whole Blood

Development and Validation of a Novel Flow Cytometric Assay for Quantification of Plasma ADAMTS-13 Activity (AD13a-FCA)

Müller, M.

The Gut Microbiota Restricts NETosis in Mesenteric Ischemia-reperfusion Injury

Müller-Calleja, N.

Sera of Syphilis Patients Contain Antiphospholipid Antibodies with Procoagulant Properties

Münzel, T.

Cost-effectiveness of a Telemedicine-based Coagulation Service versus Routine Medical Care for the Management of Patients Receiving Vitamin K-antagonists - Results from the thrombEVAL Study

The Relation between Coagulant and Vascular Function in Adult Survivors of Childhood Cancer

Naber, K.

The Inflammatory Landscape during Myocardial Reperfusion Injury Depends on Distinct Neutrophil Phenotypes

Platelet Serotonin in Arterial and Deep Vein Thrombosis

Nadal, J.

Prompt Response and Long Term Remission of Refractory MGUS Related Acquired Hemophilia with Bortezomib

Cancer Induced Hyperfibronolysis in a 59-year-old Woman with Congenital Hyperfibrinogenemia

Experience in the Treatment of Acquired Haemophilia A (AHA) in 26 Patients in Relation to Bleeding Control and Induction of Immune Tolerance

Nadalin, S.

Combined Acquired Alpha- and Delta Storage Pool Disease in Endstage Renal Failure

Nagler, M.

Cost-effectiveness of a Telemedicine-based Coagulation Service versus Routine Medical Care for the Management of Patients Receiving Vitamin K-antagonists - Results from the thrombEVAL Study

Immunoadsorption for the Treatment of Acquired Haemophilia: A Systematic Review

A Universal Anti-Xa Assay for the Determination of Rivaroxaban and Apixaban Plasma Concentrations: An In vitro Investigation and Evaluation Study in Real-life Clinical Practice

The Relation between Coagulant and Vascular Function in Adult Survivors of Childhood Cancer

Naue, C.

NOAC Therapy is also Effective and Safe in Patients Older than 80 Years - Results of the Prospective Dresden NOAC Registry (NCT01588119)

Treatment of VTE with Rivaroxaban in Adolescents - Preliminary Findings from the Prospective Dresden NOAC Registry (NCT01588119)

Naundorf, A.

Measurement of Thrombophilic Profile under Removing DOACs from Plasma Samples

Nawroth, B.

Thermography as a Component of Telemedicine for Diagnosis, Therapy and Follow-up of Joint Bleeding, Soft-tissue Bleeding and Micro-bleeding

Nazabal, A.

The FXIIIA₂B₂ Heterotetrameric Complex Structure: Unequal Pairing within a Symmetric Complex

Negrier, C.

Emicizumab Prophylaxis Administered Once-weekly or Every Two Weeks Provides Effective Bleed Prevention in Persons with Hemophilia A (PwHA) without Inhibitors - Results from the Phase III HAVEN 3 Study

Emicizumab Prophylaxis Administered Once-weekly or Every Two Weeks Provides Effective Bleed Prevention in Persons with Hemophilia A (PwHA) without Inhibitors - Results from the Phase III HAVEN 3 Study

Neu, M.A.

The Relation between Coagulant and Vascular Function in Adult Survivors of Childhood Cancer

Nguyen, T.-H.

Distinct Binding Characteristics of Pathogenic Anti-platelet Factor 4/polyanion Antibodies to their Antigen Coated on Different Substrates

Nguyen, T.S.

EPCR Raft Signaling Controls Activity of Hematopoietic Progenitor and Stem Cells

Nieswandt, B.

Platelet Lamellipodia Formation is not Required for Thrombus Formation and Stability

Platelet Lamellipodia Formation is not Required for Thrombus Formation and Stability

Nieuwland, R.

Intraperitoneal Activation of Blood Coagulation via Tissue Factor Exposing Extracellular Vesicles in Patients with Liver Disease and Ascites

Niggli, M.

Emicizumab Prophylaxis Administered Once-weekly or Every Two Weeks Provides Effective Bleed Prevention in Persons with Hemophilia A (PwHA) without Inhibitors - Results from the Phase III HAVEN 3 Study

Emicizumab Prophylaxis Administered Once-weekly or Every Two Weeks Provides Effective Bleed Prevention in Persons with Hemophilia A (PwHA) without Inhibitors - Results from the Phase III HAVEN 3 Study

Nijkeuter, M.

Determinants of the Quality of Warfarin Control and Validation of the SAMe-TT2-R2 Score for Acute Venous Thromboembolism. An Analysis of the Hokusai-VTE Trial

Nimtz-Talaska, A.

Comparison of Electronic Documentation with Smart Medication^tm between 2014 and 2017

Treatment Pattern and Pain Related to Joint Bleeds and Non-joint Bleeds - real Life Data According to Electronic Diary Smart-medication^TM

Nitschke, M.

Incidence of Acquired Thrombotic Thrombocytopenic Purpura Episodes in adults in Germany: Results of a Hospital Level Study and Projection to National Estimates

Norris, P.A.A.

Anti-Glycoprotein V Autoantibodies in Patients with Immune Thrombocytopenia

Nowak, G.

Measurement of Platelet's Count in different Anticoagulants should be Performed in Each Routine Blood Test

Nowak-Göttl, U.

Role of Gender and ABO-blood Group in White Adolescents and Young Adult Patients with First VTE Onset

Recurrent Pediatric Stroke: The Role of Thrombophilia in a Large International Pediatric Stroke Population

Recurrent Pediatric Stroke: The Role of Thrombophilia in a Large International Pediatric Stroke Population

Nowak-Harnau, S.

Cold Storage of Platelets in Additive Solution: The Impact of Residual Plasma in Apheresis Platelet Concentrates

Nuesgen, N.

Methylation Profile of Adult and Fetal FVIII Secreting Endothelial Cells in Comparison to other Endothelial Cells

Nüsgen, N.

F8 Heavy vs Light Chain Located Pre-terminal Stop Codon (PTC): Comparing the Intracellular Fate of Endogenous FVIII Variants in IPS Derived Endothelial Cells

Obser, T.

Investigation of VWD Type 2B Variants by Light Transmission Aggregometry

Oenning, S.

Some Plasma Derived FVIII Concentrates Activated FXII Leading to Kallikrein and Bradykinin Formation In vitro, while Recombinant FVIII Concentrates did not

Ojima, T.

Risk of Venous and Arterial Thromboembolism among Japanese Users of Oral Contraceptives

Oldenburg, J.

Prompt Response and Long Term Remission of Refractory MGUS Related Acquired Hemophilia with Bortezomib

Correlation of Genotype and Phenotype in Congenital FXI Deficiency

Calcium Binding to FXIII-A Subunit: Unique Characteristics

The FXIIIA₂B₂ Heterotetrameric Complex Structure: Unequal Pairing within a Symmetric Complex

Determination of ɣ-carboxylation Pattern of Different Vitamin K Dependent Proteins with Respect to VKCFD1 Phenotype

The Activated Protein C (APC) Response to In vivo Thrombin Formation Correlates with the Thrombotic Risk in Factor V Leiden but not in Prothrombin G20210A Carriers

Emicizumab Prophylaxis Administered Once-weekly or Every Two Weeks Provides Effective Bleed Prevention in Persons with Hemophilia A (PwHA) without Inhibitors - Results from the Phase III HAVEN 3 Study

Baseline Data from a 24-month Prospective, Non-interventional, Multicentre Study in Germany to Evaluate the Real-world Usage and Effectiveness of rFVIIIFc and rFIXFc in Patients with Haemophilia A or B (PREVENT)

Cancer Induced Hyperfibronolysis in a 59-year-old Woman with Congenital Hyperfibrinogenemia

Methylation Profile of Adult and Fetal FVIII Secreting Endothelial Cells in Comparison to other Endothelial Cells

Experience in the Treatment of Acquired Haemophilia A (AHA) in 26 Patients in Relation to Bleeding Control and Induction of Immune Tolerance

Thrombocytopenia Related to Defects in Platelet Cytoskeleton Regulation Genes

Derivation of Patient Specific iPSCs and iHEP Cell Lines as a Tool to Investigate VKCFD2 in a Native Cellular Environment

Emicizumab Prophylaxis Administered Once-weekly or Every Two Weeks Provides Effective Bleed Prevention in Persons with Hemophilia A (PwHA) without Inhibitors - Results from the Phase III HAVEN 3 Study

Using an Oligonucleotide-based Enzyme Capture Assay and Physiological Activation by the Thrombin-Thrombomodulin Complex Improves Protein C Deficiency Testing

F8 Heavy vs Light Chain Located Pre-terminal Stop Codon (PTC): Comparing the Intracellular Fate of Endogenous FVIII Variants in IPS Derived Endothelial Cells

Monitoring of Emicizumab using a Two-stage chromogenic tenase platform: assay Development and Validation

Flow Cytometric Quantification of Human Platelet Membrane Glycoproteins in Citrated Whole Blood

Development and Validation of a Novel Flow Cytometric Assay for Quantification of Plasma ADAMTS-13 Activity (AD13a-FCA)

A Novel Missense Mutation in ITGB3 Gene Causing Autosomal Dominant Glanzmann Thrombasthenia

Efficacy and Safety of rVIII-SingleChain in Controlling Surgical Hemostasis

Successful Treatment with Emicizumab of a Patient with Severe Haemophilia A and Factor VIII Inhibitors

Switching to rVIII-SingleChain Ensures Bleeding Protection and may Reduce Injection Frequency or Consumption in Hemophilia A Patients: Real-world Clinical Experience in Adults/Adolescents and Pediatric Patients

Prophylaxis with Extended Dosing of BAY94-9027 Decreases Overall and Joint Bleeding Rates with Consistent Consumption for Over 4 Years of Treatment

Severe Arterial Forearm Thrombosis in an 11-year-old Girl with Homozygous Antithrombin Deficiency typ IIb Budapest 3 and Mild Factor VII Deficiency Due to Homozygous Polymorphisms in the Factor 7 Gene and Antithrombotic Treatment

Haemophilia A Prophylaxis with FVIII in Real-life: Snapshot Analysis on the Observational Study “Prevention of Bleeding in Haemophilia A by Prophylactic Treatment with Octanate^®, Wilate^® or Nuwiq^® - NIS Previq”

Oleksandra, Stasyshyn

Results from a Phase 3, Randomized, Multicenter Study of Rurioctocog alfa Pegol PK-Guided Prophylaxis Targeting 2 FVIII Trough Levels in Patients with Severe Hemophilia a (Propel Study)

Olivieri, M.

GEPHARD - the PUP Cohort of the `Standing Commission Paediatrics of the Society for Thrombosis and Haemostasis Research´ - A Progress Report

Switching to rVIII-SingleChain Ensures Bleeding Protection and may Reduce Injection Frequency or Consumption in Hemophilia A Patients: Real-world Clinical Experience in Adults/Adolescents and Pediatric Patients

Vaccination in Patients with Hemophilia - Results from an Online Survey among German Haemostaseologists

Ong, J.

Efficacy and Safety of rVIII-SingleChain in Controlling Surgical Hemostasis

Orlikowsky, T.

Plasma-derived Factor X Therapy for Treatment of Intracranial Bleeding in a Patient with Factor X Deficiency: A Case Report

Orlov, A.

Correlation between Indicators of Endogenous Vascular Regulation and System of Hemostasis in Burn Patients

Orlovic, M.

GECAT - German Evaluation of Cancer associated Thrombosis: A Prospective Register Trial for Patients with Active Cancer and Venous Thromboembolism in Berlin

Orlowski, A.

Responsiveness of PBMCs Isolated from Healthy Individuals towards rFVIII and rFVIIIFc

The Evolution of Antibody Response during Immune Tolerance INDUCTION IN PAtients with Severe Hemophilia A Predicts Outcome

Identification of Plasma Cytokine Levels Correlating with FVIII Inhibitor Titer during ITI

Affinities of FVIII-specific IgG1 and IgG4 during ITI

Ortis, S.

Results from a Phase 3, Multicenter, Noninferiority Study of Ravulizumab (ALXN1210) versus Eculizumab (ECU) in Adult Patients (pts) with Paroxysmal Nocturnal Hemoglubinuria (PNH) Naive to Complement Inhibitors (CI)

Osman, M.

In Silico Analysis of Single Nucleotide Polymorphism in Human Prothrombin Gene

Osuchowski, M.

Plasmin-induced Alterations to Platelet GPIIb/IIIa Receptors Impair Secondary Blood Clot Firmness

P'Ng, S.

Efficacy and Safety of rVIII-SingleChain in Controlling Surgical Hemostasis

Paarup, H.M.

Case of Severe, Prolonged TTP - Course of Platelet Count, ADAMTS13 Enzyme Activity and Inhibitor Levels Over Time in Correlation to Treatment

Pabinger, I.

Altered Protein Profiles in Platelets of Lupus Anticoagulant Positive Patients - New Players in LA-related Thrombosis?

Citrullinated Histone H3, a Biomarker for Neutrophil Extracellular Trap Formation, Predicts the Risk of Mortality in Patients with Cancer

Intraperitoneal Activation of Blood Coagulation via Tissue Factor Exposing Extracellular Vesicles in Patients with Liver Disease and Ascites

Programmed Cell Death Ligand 1 and Venous Thromboembolism in Patients with Primary Brain Tumors

Long-term Efficacy and Safety of rVIII-SingleChain in Patients with Severe Hemophilia A: Interim Results of an Extension Study

Long-term Safety and Efficacy of rIX-FP in Patients with Hemophilia B: Intermediate Results from a Phase IIIb Extension Study

Efficacy and Safety of rVIII-SingleChain in Controlling Surgical Hemostasis

Prophylaxis with Extended Dosing of BAY94-9027 Decreases Overall and Joint Bleeding Rates with Consistent Consumption for Over 4 Years of Treatment

Pachler, C.

Ticagrelor Inhibits the Functional Assay for Heparin-induced Thrombocytopenia

Pachlinger, R.

Selective Measurement of Human Factor IX Padua Activity in Citrated Goat Plasma

Palankar, R.

Single-molecule Labeling and Tracking of FcγRIIA on Human Platelets Reveals Differential Mobility Dynamics, which Depends on Platelet Cytoskeletal Integrity

Single-molecule Labeling and Tracking of FcγRIIA on Human Platelets Reveals Differential Mobility Dynamics, which Depends on Platelet Cytoskeletal Integrity

Heterogeneity in Agonist-induced Activation Responses and Thrombus Formation: Differences between Large and Small Platelets

Panova-Noeva, M.

The Relation between Coagulant and Vascular Function in Adult Survivors of Childhood Cancer

Pappelbaum, K.I.

The Endothelial Glycocalyx Contributes to the Anchorage of von Willebrand Factor Fibers to the Vascular Endothelium

Pavenski, K.

Safety Results Normalized to Time of Exposure during the Phase 3 HERCULES Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura

Risk Factors and Manageability of the Mucocutaneous Bleeding Profile Observed in aTTP Patients Treated with Caplacizumab during the Phase III HERCULES Study

Safety Results Normalized to Time of Exposure during the Phase 3 HERCULES Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura

Pavlikova, A.

The Comparison of Manual and Automatic Interference Determination on Coagulometers ACL Top 750 CTS and Roche Cobas t511 for Routine Coagulation Tests

Pavlova, A.

Correlation of Genotype and Phenotype in Congenital FXI Deficiency

Thrombocytopenia Related to Defects in Platelet Cytoskeleton Regulation Genes

A Novel Missense Mutation in ITGB3 Gene Causing Autosomal Dominant Glanzmann Thrombasthenia

Paz-Priel, I.

Emicizumab Prophylaxis Administered Once-weekly or Every Two Weeks Provides Effective Bleed Prevention in Persons with Hemophilia A (PwHA) without Inhibitors - Results from the Phase III HAVEN 3 Study

Emicizumab Prophylaxis Administered Once-weekly or Every Two Weeks Provides Effective Bleed Prevention in Persons with Hemophilia A (PwHA) without Inhibitors - Results from the Phase III HAVEN 3 Study

Pekrul, I.

Emicizumab and its Impact on aPTT-based Assays and FVIII Inhibitor Measurement

Functional Characterisation of a von Willebrand Factor Concentrate with Low Factor VIII Content - Multimeric and Flow Chamber Analysis and a Case Report

Monitoring of Emicizumab and Factor VIII Concentrate Interaction

Pellequer, J.-L.

The FXIIIA₂B₂ Heterotetrameric Complex Structure: Unequal Pairing within a Symmetric Complex

Pelzl, L.

Phosphate-induced ORAI1 Expression and Store Operated Ca²⁺ Entry in Megakaryocytes

Pessoa, V.

Results from a Phase 3, Multicenter, Noninferiority Study of Ravulizumab (ALXN1210) versus Eculizumab (ECU) in Adult Patients (pts) with Paroxysmal Nocturnal Hemoglubinuria (PNH) Naive to Complement Inhibitors (CI)

Pestel, S.

Improving the FVIII Binding Affinity of a Recombinant VWF D'D3-albumin Fusion Molecule Translates to Dosing Benefits with Respect to the Half-life Extension of Co-administered FVIII

Peter, Collins

Results from a Phase 3, Randomized, Multicenter Study of Rurioctocog alfa Pegol PK-Guided Prophylaxis Targeting 2 FVIII Trough Levels in Patients with Severe Hemophilia a (Propel Study)

Peyvandi, F.

Efficacy and Safety of Fibrinogen Concentrate for On-demand Treatment of Acute Bleeding and for Surgical Prophylaxis in Subjects with Congenital Fibrinogen Deficiency - A Phase 3 Study

Safety Results Normalized to Time of Exposure during the Phase 3 HERCULES Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura

Risk Factors and Manageability of the Mucocutaneous Bleeding Profile Observed in aTTP Patients Treated with Caplacizumab during the Phase III HERCULES Study

Safety Results Normalized to Time of Exposure during the Phase 3 HERCULES Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura

Pezeshkpoor, B.

Correlation of Genotype and Phenotype in Congenital FXI Deficiency

Thrombocytopenia Related to Defects in Platelet Cytoskeleton Regulation Genes

A Novel Missense Mutation in ITGB3 Gene Causing Autosomal Dominant Glanzmann Thrombasthenia

Pfeiler, S.

Pancreatic Tumor Microvesicles Invade Immune Cells via CD36 and Distinctly Promote Tumor-associated Deep Vein Thrombosis

Pfrepper, C.

Changes in Hemophilia Treatment in Eastern Germany in the Last Decade - A Survey from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)

Changes in Hemophilia Treatment in Eastern Germany in the Last Decade - A Survey from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)

Vaccination in Patients with Hemophilia - Results from an Online Survey among German Haemostaseologists

Philippou, H.

Calcium Binding to FXIII-A Subunit: Unique Characteristics

Pieper, K.

Management of Venous Thromboembolism in Routine Clinical Practice - Results from the Global GARFIELD-VTE Registry

Pieske, B.

Phosphate-induced ORAI1 Expression and Store Operated Ca²⁺ Entry in Megakaryocytes

Pietrzak-Büttner, A.

Changes in Hemophilia Treatment in Eastern Germany in the Last Decade - A Survey from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)

Changes in Hemophilia Treatment in Eastern Germany in the Last Decade - A Survey from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)

Pilch, J.

Glioblastoma Cell Adhesion and Invasion in Fibrin is Promoted through β₃ Integrin

Pillitteri, D.

Severe Thrombocytopenia and Platelet Granule Dysfunction Associated with the Combination of Novel Heterozygous Variants in TUBB1 and ITGB3

Pipe, S.W.

Phase 2b Trial of AMT-061 (AAV5-Padua hFIX): Translation into Humans of an Enhanced Gene Transfer Vector for Adults with Severe or Moderate-severe Hemophilia B

HOPE-B: Study Design of a Phase III trial of an Investigational Gene Therapy AMT-061 in Subjects with Severe or Moderately Severe Hemophilia B

Platunova, M.

Venous Thromboembolism Risks Modeling in Burn Patients

Pollich, C.

GECAT - German Evaluation of Cancer associated Thrombosis: A Prospective Register Trial for Patients with Active Cancer and Venous Thromboembolism in Berlin

Ponschab, M.

Plasmin-induced Alterations to Platelet GPIIb/IIIa Receptors Impair Secondary Blood Clot Firmness

Modified ROTEM^® xxtem Clotting Time Shows better Correlation with Endogenous Thrombin Potential than Standard Extem

Portnov, S.

The Kinetics of Platelet-derived Microparticles in Patients with ST Segment Elevation Acute Myocardial Infarction under Pharmacological Suppression of Platelet Aggregation

Posch, F.

Citrullinated Histone H3, a Biomarker for Neutrophil Extracellular Trap Formation, Predicts the Risk of Mortality in Patients with Cancer

Programmed Cell Death Ligand 1 and Venous Thromboembolism in Patients with Primary Brain Tumors

Pötzsch, B.

The Activated Protein C (APC) Response to In vivo Thrombin Formation Correlates with the Thrombotic Risk in Factor V Leiden but not in Prothrombin G20210A Carriers

Using an Oligonucleotide-based Enzyme Capture Assay and Physiological Activation by the Thrombin-Thrombomodulin Complex Improves Protein C Deficiency Testing

Monitoring of Emicizumab using a Two-stage chromogenic tenase platform: assay Development and Validation

Flow Cytometric Quantification of Human Platelet Membrane Glycoproteins in Citrated Whole Blood

Development and Validation of a Novel Flow Cytometric Assay for Quantification of Plasma ADAMTS-13 Activity (AD13a-FCA)

A Novel Missense Mutation in ITGB3 Gene Causing Autosomal Dominant Glanzmann Thrombasthenia

Severe Arterial Forearm Thrombosis in an 11-year-old Girl with Homozygous Antithrombin Deficiency typ IIb Budapest 3 and Mild Factor VII Deficiency Due to Homozygous Polymorphisms in the Factor 7 Gene and Antithrombotic Treatment

Pradhan, R.

Results from a Phase 3, Multicenter, Noninferiority Study of Ravulizumab (ALXN1210) versus Eculizumab (ECU) in Adult Patients (pts) with Paroxysmal Nocturnal Hemoglubinuria (PNH) Naive to Complement Inhibitors (CI)

Preisler, B.

Correlation of Genotype and Phenotype in Congenital FXI Deficiency

Preissner, K.T.

Inflammatory Function of Ribosomal RNA-containing Microvesicles from Mast Cells

Prengler, M.

Recurrent Pediatric Stroke: The Role of Thrombophilia in a Large International Pediatric Stroke Population

Recurrent Pediatric Stroke: The Role of Thrombophilia in a Large International Pediatric Stroke Population

Preusser, M.

Programmed Cell Death Ligand 1 and Venous Thromboembolism in Patients with Primary Brain Tumors

Prochaska, J.H.

Cost-effectiveness of a Telemedicine-based Coagulation Service versus Routine Medical Care for the Management of Patients Receiving Vitamin K-antagonists - Results from the thrombEVAL Study

The Relation between Coagulant and Vascular Function in Adult Survivors of Childhood Cancer

Prüller, F.

New Normal Ranges Measuring APC Resistance on a New Coagulation Analyzer (COAG360)

Ptushkin, V.

Results from a Phase 3, Multicenter, Noninferiority Study of Ravulizumab (ALXN1210) versus Eculizumab (ECU) in Adult Patients (pts) with Paroxysmal Nocturnal Hemoglubinuria (PNH) Naive to Complement Inhibitors (CI)

Puchnyan, N.

The Kinetics of Platelet-derived Microparticles in Patients with ST Segment Elevation Acute Myocardial Infarction under Pharmacological Suppression of Platelet Aggregation

Puhr, H.C.

Risk and Determinants of Provoked Recurrent Venous Thromboembolism: A Prospective Cohort Study

Quehenberger, P.

Emicizumab for the Treatment of Acquired Hemophilia A: Lessons Learned from 4 very Different Cases

Intraperitoneal Activation of Blood Coagulation via Tissue Factor Exposing Extracellular Vesicles in Patients with Liver Disease and Ascites

Quist-Paulsen, P.

More severe ADAMTS13 Deficiency in Homozygous versus Compound Heterozygous Carriers of the ADAMTS13 c.4143_4144dupA Mutation in Congenital Thrombotic Thrombocytopenic Purpura (cTTP): Impact on Disease Onset?

Rabensteiner, J.

New Normal Ranges Measuring APC Resistance on a New Coagulation Analyzer (COAG360)

Ramiro, V.

Development of Deep Vein Thrombosis after Achieving Remission in a Patient with Acquired Hemophilia A

Rangarajan, S.

Fibrinogen Concentrate vs Cryoprecipitate in Pseudomyxoma Peritonei Surgery: Interim Results from a Prospective, Randomized, Controlled Phase 2 Study

Ranjan, S.

Thrombomodulin Regulates Platelet and Extracellular Vesicle Mediated Sterile Inflammation in the Placenta

Thrombomodulin Regulates Platelet and Extracellular Vesicle Mediated Sterile Inflammation in the Placenta

Raquet, E.

Improving the FVIII Binding Affinity of a Recombinant VWF D'D3-albumin Fusion Molecule Translates to Dosing Benefits with Respect to the Half-life Extension of Co-administered FVIII

Raschke, R.

Ticagrelor Inhibits the Functional Assay for Heparin-induced Thrombocytopenia

Rath, D.

Platelet Lipidome and Lipid Induced Thromboinflammatory Actions are Influenced by the CXCL12-CXCR4-CXCR7 Axis

Platelet Lipidome and Lipid Induced Thromboinflammatory Actions are Influenced by the CXCL12-CXCR4-CXCR7 Axis

Rath, M.

F8 Heavy vs Light Chain Located Pre-terminal Stop Codon (PTC): Comparing the Intracellular Fate of Endogenous FVIII Variants in IPS Derived Endothelial Cells

Rauterberg, S.

Platelet-leukocyte Complex Formation is Associated with, but Dispensable for Myocardial Ischemia Reperfusion Injury

Recht, M.

Phase 2b Trial of AMT-061 (AAV5-Padua hFIX): Translation into Humans of an Enhanced Gene Transfer Vector for Adults with Severe or Moderate-severe Hemophilia B

HOPE-B: Study Design of a Phase III trial of an Investigational Gene Therapy AMT-061 in Subjects with Severe or Moderately Severe Hemophilia B

Reda, S.

The Activated Protein C (APC) Response to In vivo Thrombin Formation Correlates with the Thrombotic Risk in Factor V Leiden but not in Prothrombin G20210A Carriers

Using an Oligonucleotide-based Enzyme Capture Assay and Physiological Activation by the Thrombin-Thrombomodulin Complex Improves Protein C Deficiency Testing

Rehberg, S.

Comparison of a New Prototype for Rapid Thawing of Fresh Frozen Plasma with Two Commercially Available Thawing Devices

Reiberger, T.

Intraperitoneal Activation of Blood Coagulation via Tissue Factor Exposing Extracellular Vesicles in Patients with Liver Disease and Ascites

Reichert, A.

Baseline Data from a 24-month Prospective, Non-interventional, Multicentre Study in Germany to Evaluate the Real-world Usage and Effectiveness of rFVIIIFc and rFIXFc in Patients with Haemophilia A or B (PREVENT)

Reinhardt, C.

The Gut Microbiota Restricts NETosis in Mesenteric Ischemia-reperfusion Injury

Remalante, P.P.

Successful Therapeutic Management and Delivery in a Pregnancy Complicated by Secondary Evans Syndrome from Systemic Lupus Erythematosus and Concurrent Antiphospholipid Syndrome

Rempel, H.

Comparison of a New Prototype for Rapid Thawing of Fresh Frozen Plasma with Two Commercially Available Thawing Devices

Reschke, M.

Congenital Protein C Deficiency: Delayed Treatment of 14 Year Old Girl causes Prolonged Treatment, Several Complications and Unfavorable Results

Reumiller, C.M.

Altered Protein Profiles in Platelets of Lupus Anticoagulant Positive Patients - New Players in LA-related Thrombosis?

Rheinlaender, J.

Platelet Lipidome and Lipid Induced Thromboinflammatory Actions are Influenced by the CXCL12-CXCR4-CXCR7 Axis

Platelet Lipidome and Lipid Induced Thromboinflammatory Actions are Influenced by the CXCL12-CXCR4-CXCR7 Axis

Richter, H.

Comparison of Electronic Documentation with Smart Medication^tm between 2014 and 2017

Treatment Pattern and Pain Related to Joint Bleeds and Non-joint Bleeds - real Life Data According to Electronic Diary Smart-medication^TM

Ricken, G.

Programmed Cell Death Ligand 1 and Venous Thromboembolism in Patients with Primary Brain Tumors

Riedl, J.

Programmed Cell Death Ligand 1 and Venous Thromboembolism in Patients with Primary Brain Tumors

Rieke, M.

Interim Results of a Non-interventional Study on Efficacy and Tolerability of a VWF/FVIII Concentrate in von Willebrand's Disease

Riess, H.

GECAT - German Evaluation of Cancer associated Thrombosis: A Prospective Register Trial for Patients with Active Cancer and Venous Thromboembolism in Berlin

Rigoni, F.

Glycan Changes on Platelet and Megakaryocyte: A Potential Impact on Platelet Function and Lifespan in Immune Thrombocytopenia

Phosphate-induced ORAI1 Expression and Store Operated Ca²⁺ Entry in Megakaryocytes

Rink, G.

Correlation of CLEC1B Gene Polymorphisms with Plasma Levels of Soluble CLEC-2 in Healthy Individuals

Ritter, S.

Sera of Syphilis Patients Contain Antiphospholipid Antibodies with Procoagulant Properties

Riva, N.

Determinants of the Quality of Warfarin Control and Validation of the SAMe-TT2-R2 Score for Acute Venous Thromboembolism. An Analysis of the Hokusai-VTE Trial

Robador, J.R.

Platelet-derived von Willebrand Factor Fosters Intracranial Hypercoagulation in Metastatic Brains of Mice and Humans

Robert, Klamroth

Results from a Phase 3, Randomized, Multicenter Study of Rurioctocog alfa Pegol PK-Guided Prophylaxis Targeting 2 FVIII Trough Levels in Patients with Severe Hemophilia a (Propel Study)

Roesch, A.

Smart medication^tm - A Pilot Study for Investigating the Feasibility of Speech Recognition of Natural Language to Access Electronic Patient Diary

Impact of GDPR (DSGVO) on Smart Medication™ Electronic Patient Diary

Rolvien, T.

Bone Mineral Density and Bone Microstructure in Patients with Haemophilia in Northern Germany: Preliminary Findings of a Single Centre Study

Rösch, A.

Smart Medication™ ITP - Feasibility of Online Surveillance in Patients with Immunthrombocytopenia

Rosenberger, P.

Acquired von Willebrand Syndrome during Mechanical Circulatory Support and Extracorporeal Membrane Oxygenation: Rapid Onset and the Demand for Point of Care Testing

Rossmann, H.

Severe Thrombocytopenia and Platelet Granule Dysfunction Associated with the Combination of Novel Heterozygous Variants in TUBB1 and ITGB3

Detection and Differential Diagnosis of Prekallikrein Deficiency: Genetic Study of New Families and Systematic Review of the Literature

Eleven Relapses in a Cohort of 78 Patients with Immune Thrombotic Thrombocytopenic Purpura (iTTP): Data from the German TTP-Registry

Rothe, R.

Quality of Plasma Collected with Closed Plasmapheresis Disposables

Rott, H.

Assessment of Joint Health in Children with Haemophilia - Results of the German Energy Study

Rottensteiner, H.

Selective Measurement of Human Factor IX Padua Activity in Citrated Goat Plasma

Rottinghaus, S.T.

Results from a Phase 3, Multicenter, Noninferiority Study of Ravulizumab (ALXN1210) versus Eculizumab (ECU) in Adult Patients (pts) with Paroxysmal Nocturnal Hemoglubinuria (PNH) Naive to Complement Inhibitors (CI)

Roy, A.

Fibrinogen Concentrate vs Cryoprecipitate in Pseudomyxoma Peritonei Surgery: Interim Results from a Prospective, Randomized, Controlled Phase 2 Study

Ruf, W.

EPCR Raft Signaling Controls Activity of Hematopoietic Progenitor and Stem Cells

Rühl, H.

The Activated Protein C (APC) Response to In vivo Thrombin Formation Correlates with the Thrombotic Risk in Factor V Leiden but not in Prothrombin G20210A Carriers

Using an Oligonucleotide-based Enzyme Capture Assay and Physiological Activation by the Thrombin-Thrombomodulin Complex Improves Protein C Deficiency Testing

Flow Cytometric Quantification of Human Platelet Membrane Glycoproteins in Citrated Whole Blood

Development and Validation of a Novel Flow Cytometric Assay for Quantification of Plasma ADAMTS-13 Activity (AD13a-FCA)

Rummel, M.J.

Anti-Glycoprotein V Autoantibodies in Patients with Immune Thrombocytopenia

Ruthenberg, J.

Systematic Comparison of MRI and ultrasound scores to Assess Arthropathy in Children and Adolescents with Hemophilia

Rybalchenko, T.

Subacute Megakaryocytopoietic Toxicity of Maleimide Derivative with Antitumor Activity

Rybalchenko, V.

Subacute Megakaryocytopoietic Toxicity of Maleimide Derivative with Antitumor Activity

Sachkov, A.

New Oral Anticoagulants for Prevention of Complications of Venous Thromboembolism in Burn Patients

Sachs, U.J.

Successful Control of Bleeding with Emicizumab in Aquired Haemophilia A: A Case Report

Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT): Evidence that Placental rather than Systemic Inflammation is a Modulator of Disease Severity

Direct Oral Anticoagulants in Patients with Antiphospholipid Syndrome: Results from a Retrospective Study in a Real-life Patient Cohort

Anti-Glycoprotein V Autoantibodies in Patients with Immune Thrombocytopenia

Direct Oral Anticoagulants in Patients with Antiphospholipid Syndrome: Results from a Retrospective Study in a Real-life Patient Cohort

Safronenko, A.

The Assessment of the Frequency of Complications in the Analysis of the Time Interval between Anticoagulants and Haemostatic Drugs among Patients after the Total Knee and Hip Replacement

Sahu, I.

Phosphate-induced ORAI1 Expression and Store Operated Ca²⁺ Entry in Megakaryocytes

Salazar-Chacon, C.

Hereditary Haemorrhagic Telangiectasia (HHT) as an Important Rare Haemorrhagic Disorder in Costa Rica - Report of Costa Rica

Salazar-Sanchez, L.

Hereditary Haemorrhagic Telangiectasia (HHT) as an Important Rare Haemorrhagic Disorder in Costa Rica - Report of Costa Rica

Samasca, G.

Determination of Age Dependent Reference Ranges for PT and aPTT

Sangalli-Baruffaldi, J.

A Universal Anti-Xa Assay for the Determination of Rivaroxaban and Apixaban Plasma Concentrations: An In vitro Investigation and Evaluation Study in Real-life Clinical Practice

Santagostino, E.

Long-term Safety and Efficacy of rIX-FP in Patients with Hemophilia B: Intermediate Results from a Phase IIIb Extension Study

Population Pharmacokinetic Analysis of Recombinant Fusion Protein Linking Coagulation Factor IX with Recombinant Albumin (rIX-FP) in Adult and Pediatric Patients with Severe Hemophilia B

Systematic Review of Efficacy of Recombinant Factor IX Products for Prophylactic Treatment of Hemophilia B

Sapkota, A.

Metabolome Analysis for New Possible Hemostasis Biomarkers

Sargent, N.

Fibrinogen Concentrate vs Cryoprecipitate in Pseudomyxoma Peritonei Surgery: Interim Results from a Prospective, Randomized, Controlled Phase 2 Study

Schäffer, T.E.

Platelet Lipidome and Lipid Induced Thromboinflammatory Actions are Influenced by the CXCL12-CXCR4-CXCR7 Axis

Platelet Lipidome and Lipid Induced Thromboinflammatory Actions are Influenced by the CXCL12-CXCR4-CXCR7 Axis

Schaller, M.

Anti-ADAMTS13 Autoantibody-specific Anti-idiotypic Antibodies Restore ADAMTS13 Activity in Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP) Patients

Anti-ADAMTS13 Autoantibody-specific Anti-idiotypic Antibodies Restore ADAMTS13 Activity in Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP) Patients

Scharrer, I.

Eleven Relapses in a Cohort of 78 Patients with Immune Thrombotic Thrombocytopenic Purpura (iTTP): Data from the German TTP-Registry

Scheinost, M.

Plasmin-induced Alterations to Platelet GPIIb/IIIa Receptors Impair Secondary Blood Clot Firmness

Schellong, S.

Management of Venous Thromboembolism in Routine Clinical Practice - Results from the Global GARFIELD-VTE Registry

Schellongowski, P.

Emicizumab for the Treatment of Acquired Hemophilia A: Lessons Learned from 4 very Different Cases

Schilling, K.

Changes in Hemophilia Treatment in Eastern Germany in the Last Decade - A Survey from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)

Changes in Hemophilia Treatment in Eastern Germany in the Last Decade - A Survey from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)

Schinzel, H.

Cost-effectiveness of a Telemedicine-based Coagulation Service versus Routine Medical Care for the Management of Patients Receiving Vitamin K-antagonists - Results from the thrombEVAL Study

Schlagenhauf, A.

Elevated Bile Acid Levels Induce Tissue Factor Activity in Hepatocytes

Schlensak, C.

Acquired von Willebrand Syndrome during Mechanical Circulatory Support and Extracorporeal Membrane Oxygenation: Rapid Onset and the Demand for Point of Care Testing

Schmidt, A.

Responsiveness of PBMCs Isolated from Healthy Individuals towards rFVIII and rFVIIIFc

Identification of Plasma Cytokine Levels Correlating with FVIII Inhibitor Titer during ITI

Affinities of FVIII-specific IgG1 and IgG4 during ITI

Schmidt, F.P.

Treatment of High-risk Pregnancies with Tinzaparin

Schmidt, F.-P.

Protein z Deficiency in Risk Pregnant Women

Schmidt, G.J.

Altered Protein Profiles in Platelets of Lupus Anticoagulant Positive Patients - New Players in LA-related Thrombosis?

Schmidt, T.

Bone Mineral Density and Bone Microstructure in Patients with Haemophilia in Northern Germany: Preliminary Findings of a Single Centre Study

Schmidtmann, I.

Eleven Relapses in a Cohort of 78 Patients with Immune Thrombotic Thrombocytopenic Purpura (iTTP): Data from the German TTP-Registry

Schmitt, C.

Emicizumab Prophylaxis Administered Once-weekly or Every Two Weeks Provides Effective Bleed Prevention in Persons with Hemophilia A (PwHA) without Inhibitors - Results from the Phase III HAVEN 3 Study

Emicizumab Prophylaxis Administered Once-weekly or Every Two Weeks Provides Effective Bleed Prevention in Persons with Hemophilia A (PwHA) without Inhibitors - Results from the Phase III HAVEN 3 Study

Schmitz, K.

FibrinoQuick - A Rapid Fibrinogen Assay for Patient Blood Management

Schmoldt, B.

Smart Medication™ ITP - Feasibility of Online Surveillance in Patients with Immunthrombocytopenia

Schmoldt, D.

Smart medication^tm - A Pilot Study for Investigating the Feasibility of Speech Recognition of Natural Language to Access Electronic Patient Diary

Impact of GDPR (DSGVO) on Smart Medication™ Electronic Patient Diary

Schneider, A.

The Relation between Coagulant and Vascular Function in Adult Survivors of Childhood Cancer

Schneider, S.W.

The Endothelial Glycocalyx Contributes to the Anchorage of von Willebrand Factor Fibers to the Vascular Endothelium

Increased Permeability of Tumor Blood Vessels is Triggered by Membrane Attack Complex Activated Neutrophils

Platelet-derived von Willebrand Factor Fosters Intracranial Hypercoagulation in Metastatic Brains of Mice and Humans

Schneppenheim, R.

Investigation of VWD Type 2B Variants by Light Transmission Aggregometry

More severe ADAMTS13 Deficiency in Homozygous versus Compound Heterozygous Carriers of the ADAMTS13 c.4143_4144dupA Mutation in Congenital Thrombotic Thrombocytopenic Purpura (cTTP): Impact on Disease Onset?

Schober, S.

Congenital Antithrombin Deficiency Type II: A Case Report

Schöchl, H.

Plasmin-induced Alterations to Platelet GPIIb/IIIa Receptors Impair Secondary Blood Clot Firmness

Modified ROTEM^® xxtem Clotting Time Shows better Correlation with Endogenous Thrombin Potential than Standard Extem

Schoenichen, C.

The Inflammatory Landscape during Myocardial Reperfusion Injury Depends on Distinct Neutrophil Phenotypes

Scholz, C.W.

GECAT - German Evaluation of Cancer associated Thrombosis: A Prospective Register Trial for Patients with Active Cancer and Venous Thromboembolism in Berlin

Scholz, U.

Changes in Hemophilia Treatment in Eastern Germany in the Last Decade - A Survey from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)

Baseline Data from a 24-month Prospective, Non-interventional, Multicentre Study in Germany to Evaluate the Real-world Usage and Effectiveness of rFVIIIFc and rFIXFc in Patients with Haemophilia A or B (PREVENT)

Changes in Hemophilia Treatment in Eastern Germany in the Last Decade - A Survey from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)

Measurement of Thrombophilic Profile under Removing DOACs from Plasma Samples

Haemophilia A Prophylaxis with FVIII in Real-life: Snapshot Analysis on the Observational Study “Prevention of Bleeding in Haemophilia A by Prophylactic Treatment with Octanate^®, Wilate^® or Nuwiq^® - NIS Previq”

Schönermarck, U.

Incidence of Acquired Thrombotic Thrombocytopenic Purpura Episodes in adults in Germany: Results of a Hospital Level Study and Projection to National Estimates

Schönichen, C.

Platelet Serotonin in Arterial and Deep Vein Thrombosis

Schreiner, R.

Study Design for Evaluating an In Vitrodiagnostic Test for Direct Oral Anticoagulants

Schrezenmeier, H.

Results from a Phase 3, Multicenter, Noninferiority Study of Ravulizumab (ALXN1210) versus Eculizumab (ECU) in Adult Patients (pts) with Paroxysmal Nocturnal Hemoglubinuria (PNH) Naive to Complement Inhibitors (CI)

Schrotz-King, P.

Plasma Levels of Soluble CLEC-2 in Patients with Different Solid Tumors

Schulze, H.

Use of Targeted High-throughput Sequencing for Genetic Classification of Patients with Bleeding Diathesis and Suspected Platelet Disorder

Use of Targeted High-throughput Sequencing for Genetic Classification of Patients with Bleeding Diathesis and Suspected Platelet Disorder

Schurr, Y.

Platelet Lamellipodia Formation is not Required for Thrombus Formation and Stability

Platelet Lamellipodia Formation is not Required for Thrombus Formation and Stability

Schüssel, P.

Acquired von Willebrand Syndrome during Mechanical Circulatory Support and Extracorporeal Membrane Oxygenation: Rapid Onset and the Demand for Point of Care Testing

Schutgens, R.

Safety and Efficacy of Turoctocog Alfa in Severe and Moderately Severe Previously Treated Patients with Haemophilia A: Interim Results after >4,000 Exposure Days (Guardian 5)

Schwabe, D.

Identification of Plasma Cytokine Levels Correlating with FVIII Inhibitor Titer during ITI

Schwabl, P.

Intraperitoneal Activation of Blood Coagulation via Tissue Factor Exposing Extracellular Vesicles in Patients with Liver Disease and Ascites

Schwander, B.

Incidence of Acquired Thrombotic Thrombocytopenic Purpura Episodes in adults in Germany: Results of a Hospital Level Study and Projection to National Estimates

Schwartz, B.

Efficacy and Safety of Fibrinogen Concentrate for On-demand Treatment of Acute Bleeding and for Surgical Prophylaxis in Subjects with Congenital Fibrinogen Deficiency - A Phase 3 Study

Scully, M.

Safety Results Normalized to Time of Exposure during the Phase 3 HERCULES Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura

Risk Factors and Manageability of the Mucocutaneous Bleeding Profile Observed in aTTP Patients Treated with Caplacizumab during the Phase III HERCULES Study

Safety Results Normalized to Time of Exposure during the Phase 3 HERCULES Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura

Seeger, S.

Interim Results of a Non-interventional Study on Efficacy and Tolerability of a VWF/FVIII Concentrate in von Willebrand's Disease

Haemophilia A Prophylaxis with FVIII in Real-life: Snapshot Analysis on the Observational Study “Prevention of Bleeding in Haemophilia A by Prophylactic Treatment with Octanate^®, Wilate^® or Nuwiq^® - NIS Previq”

Seibert, F.

Incidence of Acquired Thrombotic Thrombocytopenic Purpura Episodes in adults in Germany: Results of a Hospital Level Study and Projection to National Estimates

Seidel, M.

Diagnosis of ETV6-mutation Related Thrombocytopenia by Immunofluorescence Microscopy

Seifert, W.

Long-term Safety and Efficacy of rIX-FP in Patients with Hemophilia B: Intermediate Results from a Phase IIIb Extension Study

Population Pharmacokinetic Analysis of Recombinant Fusion Protein Linking Coagulation Factor IX with Recombinant Albumin (rIX-FP) in Adult and Pediatric Patients with Severe Hemophilia B

Seifried, E.

In vitro and In vivo Validation of a Laboratory Assay for Monitoring Survival of Transfused Platelets: Tracking HLA Mismatch between Donor and Recipient

Selbitz, A.

Thrombocytopenia Related to Defects in Platelet Cytoskeleton Regulation Genes

Seneres, A.

Successful Therapeutic Management and Delivery in a Pregnancy Complicated by Secondary Evans Syndrome from Systemic Lupus Erythematosus and Concurrent Antiphospholipid Syndrome

Severin, K.

Comparison of Electronic Documentation with Smart Medication^tm between 2014 and 2017

Treatment Pattern and Pain Related to Joint Bleeds and Non-joint Bleeds - real Life Data According to Electronic Diary Smart-medication^TM

Shafner, L.

Results from a Phase 3, Multicenter, Noninferiority Study of Ravulizumab (ALXN1210) versus Eculizumab (ECU) in Adult Patients (pts) with Paroxysmal Nocturnal Hemoglubinuria (PNH) Naive to Complement Inhibitors (CI)

Shahidi, N. Hamedani

Monitoring of Emicizumab using a Two-stage chromogenic tenase platform: assay Development and Validation

Shahidi-Hamedani, N.

Development and Validation of a Novel Flow Cytometric Assay for Quantification of Plasma ADAMTS-13 Activity (AD13a-FCA)

Shima, M.

Emicizumab Prophylaxis Administered Once-weekly or Every Two Weeks Provides Effective Bleed Prevention in Persons with Hemophilia A (PwHA) without Inhibitors - Results from the Phase III HAVEN 3 Study

Emicizumab Prophylaxis Administered Once-weekly or Every Two Weeks Provides Effective Bleed Prevention in Persons with Hemophilia A (PwHA) without Inhibitors - Results from the Phase III HAVEN 3 Study

Sicre de Fontbrune, F.

Results from a Phase 3, Multicenter, Noninferiority Study of Ravulizumab (ALXN1210) versus Eculizumab (ECU) in Adult Patients (pts) with Paroxysmal Nocturnal Hemoglubinuria (PNH) Naive to Complement Inhibitors (CI)

Sidhu, J.

Population Pharmacokinetic Analysis of Recombinant Fusion Protein Linking Coagulation Factor IX with Recombinant Albumin (rIX-FP) in Adult and Pediatric Patients with Severe Hemophilia B

Siebert, M.

Development of an Adherence Questionnaire for Haemophilia Patients of the German Health System

Assessment of Joint Health in Children with Haemophilia - Results of the German Energy Study

Sievers, B.

LPS-induced Expression of Monocyte Tissue Factor (TF) Antigen Correlates with Markers of Systemic Inflammation in Patients with Hemophilia A and B

Myeloperoxidase (MPO) Inhibits the Procoagulant Activity (PCA) of Extracellular DNA

Sigl-Kraetzig, M.

Systematic Comparison of MRI and ultrasound scores to Assess Arthropathy in Children and Adolescents with Hemophilia

Vaccination in Patients with Hemophilia - Results from an Online Survey among German Haemostaseologists

Singer, H.

Derivation of Patient Specific iPSCs and iHEP Cell Lines as a Tool to Investigate VKCFD2 in a Native Cellular Environment

F8 Heavy vs Light Chain Located Pre-terminal Stop Codon (PTC): Comparing the Intracellular Fate of Endogenous FVIII Variants in IPS Derived Endothelial Cells

Singh, S.

Calcium Binding to FXIII-A Subunit: Unique Characteristics

The FXIIIA₂B₂ Heterotetrameric Complex Structure: Unequal Pairing within a Symmetric Complex

Sinkovec, H.

Risk and Determinants of Provoked Recurrent Venous Thromboembolism: A Prospective Cohort Study

Sinn, M.

GECAT - German Evaluation of Cancer associated Thrombosis: A Prospective Register Trial for Patients with Active Cancer and Venous Thromboembolism in Berlin

Sirb, H.

Changes in Hemophilia Treatment in Eastern Germany in the Last Decade - A Survey from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)

Changes in Hemophilia Treatment in Eastern Germany in the Last Decade - A Survey from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)

Slavik, L.

The Comparison of Manual and Automatic Interference Determination on Coagulometers ACL Top 750 CTS and Roche Cobas t511 for Routine Coagulation Tests

Slonka, J.

Successful Control of Bleeding with Emicizumab in Aquired Haemophilia A: A Case Report

Smith, G.

Effects of WSCM, eVCM and Nicotine on monocyte adhesion to human aortic endothelial cells

Soliman, A.

In Silico Analysis of Single Nucleotide Polymorphism in Human Prothrombin Gene

Sollfrank, S.

Severe Thrombocytopenia and Platelet Granule Dysfunction Associated with the Combination of Novel Heterozygous Variants in TUBB1 and ITGB3

Detection and Differential Diagnosis of Prekallikrein Deficiency: Genetic Study of New Families and Systematic Review of the Literature

Solomon, C.

Efficacy and Safety of Fibrinogen Concentrate for On-demand Treatment of Acute Bleeding and for Surgical Prophylaxis in Subjects with Congenital Fibrinogen Deficiency - A Phase 3 Study

Fibrinogen Concentrate vs Cryoprecipitate in Pseudomyxoma Peritonei Surgery: Interim Results from a Prospective, Randomized, Controlled Phase 2 Study

Sopivnik, I.

Quality of Plasma Collected with Closed Plasmapheresis Disposables

Sousa, R.

Safety Results Normalized to Time of Exposure during the Phase 3 HERCULES Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura

Risk Factors and Manageability of the Mucocutaneous Bleeding Profile Observed in aTTP Patients Treated with Caplacizumab during the Phase III HERCULES Study

Safety Results Normalized to Time of Exposure during the Phase 3 HERCULES Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura

Incidence of Acquired Thrombotic Thrombocytopenic Purpura Episodes in adults in Germany: Results of a Hospital Level Study and Projection to National Estimates

Spannagl, M.

Emicizumab and its Impact on aPTT-based Assays and FVIII Inhibitor Measurement

Functional Characterisation of a von Willebrand Factor Concentrate with Low Factor VIII Content - Multimeric and Flow Chamber Analysis and a Case Report

Spannnagl, M.

Monitoring of Emicizumab and Factor VIII Concentrate Interaction

Späth-Schwalbe, E.

GECAT - German Evaluation of Cancer associated Thrombosis: A Prospective Register Trial for Patients with Active Cancer and Venous Thromboembolism in Berlin

Sperr, A.

Platelet Lamellipodia Formation is not Required for Thrombus Formation and Stability

Platelet Lamellipodia Formation is not Required for Thrombus Formation and Stability

Sperr, W.

Emicizumab for the Treatment of Acquired Hemophilia A: Lessons Learned from 4 very Different Cases

Spors, B.

Systematic Comparison of MRI and ultrasound scores to Assess Arthropathy in Children and Adolescents with Hemophilia

Sprogøe, U.

Case of Severe, Prolonged TTP - Course of Platelet Count, ADAMTS13 Enzyme Activity and Inhibitor Levels Over Time in Correlation to Treatment

Spronk, H.M.

The Relation between Coagulant and Vascular Function in Adult Survivors of Childhood Cancer

Srilatha, Tangada

Results from a Phase 3, Randomized, Multicenter Study of Rurioctocog alfa Pegol PK-Guided Prophylaxis Targeting 2 FVIII Trough Levels in Patients with Severe Hemophilia a (Propel Study)

Stachon, P.

Platelet-leukocyte Complex Formation is Associated with, but Dispensable for Myocardial Ischemia Reperfusion Injury

Stallmann, D.

The Inflammatory Landscape during Myocardial Reperfusion Injury Depends on Distinct Neutrophil Phenotypes

Stanford, S.

Fibrinogen Concentrate vs Cryoprecipitate in Pseudomyxoma Peritonei Surgery: Interim Results from a Prospective, Randomized, Controlled Phase 2 Study

Stark, K.

Pancreatic Tumor Microvesicles Invade Immune Cells via CD36 and Distinctly Promote Tumor-associated Deep Vein Thrombosis

Starz, C.

Platelet-leukocyte Complex Formation is Associated with, but Dispensable for Myocardial Ischemia Reperfusion Injury

Stasyshyn, O.

Long-term Efficacy and Safety of rVIII-SingleChain in Patients with Severe Hemophilia A: Interim Results of an Extension Study

Staudinger, T.

Emicizumab for the Treatment of Acquired Hemophilia A: Lessons Learned from 4 very Different Cases

Stein, P.

A Universal Anti-Xa Assay for the Determination of Rivaroxaban and Apixaban Plasma Concentrations: An In vitro Investigation and Evaluation Study in Real-life Clinical Practice

Steiner, M.

A New Rapid, Specific, and Simple ELISA for von Willebrand Factor Propeptide

Stichel, D.

The Evolution of Antibody Response during Immune Tolerance INDUCTION IN PAtients with Severe Hemophilia A Predicts Outcome

Identification of Plasma Cytokine Levels Correlating with FVIII Inhibitor Titer during ITI

Affinities of FVIII-specific IgG1 and IgG4 during ITI

Stockschläder, A.

Successful Control of Bleeding with Emicizumab in Aquired Haemophilia A: A Case Report

Stoll, M.

Role of Gender and ABO-blood Group in White Adolescents and Young Adult Patients with First VTE Onset

Recurrent Pediatric Stroke: The Role of Thrombophilia in a Large International Pediatric Stroke Population

Recurrent Pediatric Stroke: The Role of Thrombophilia in a Large International Pediatric Stroke Population

Storozheva, M.

Nanosilver Induce Platelet Pro-thrombotic Ability in Norm and Pathology

Strasser, E.F.

Establishment of Various Specific Parameters for the Routine Diagnostics in Patients with Glanzmann Thrombasthenia

Sträter, R.

Recurrent Pediatric Stroke: The Role of Thrombophilia in a Large International Pediatric Stroke Population

Recurrent Pediatric Stroke: The Role of Thrombophilia in a Large International Pediatric Stroke Population

Straub, A.

A New Method to Assess Platelet Activation and Leukocyte-platelet Aggregates in Whole Blood Samples by Flow Cytometry for Clinical Studies

Acquired von Willebrand Syndrome during Mechanical Circulatory Support and Extracorporeal Membrane Oxygenation: Rapid Onset and the Demand for Point of Care Testing

Straussinsky, M.

Acquired von Willebrand Syndrome during Mechanical Circulatory Support and Extracorporeal Membrane Oxygenation: Rapid Onset and the Demand for Point of Care Testing

Streif, W.

Prevalence of Paroxysmal Nocturnal Hemoglobinuria in Children with Thrombosis - A Retrospective Cohort Study

Strobel, U.

Ticagrelor Inhibits the Functional Assay for Heparin-induced Thrombocytopenia

Studt, J.-D.

A Universal Anti-Xa Assay for the Determination of Rivaroxaban and Apixaban Plasma Concentrations: An In vitro Investigation and Evaluation Study in Real-life Clinical Practice

Stupar, A.

Correlation of Genotype and Phenotype in Congenital FXI Deficiency

Stuplich, C.

Severe Arterial Forearm Thrombosis in an 11-year-old Girl with Homozygous Antithrombin Deficiency typ IIb Budapest 3 and Mild Factor VII Deficiency Due to Homozygous Polymorphisms in the Factor 7 Gene and Antithrombotic Treatment

Sugiura, K.

Risk of Venous and Arterial Thromboembolism among Japanese Users of Oral Contraceptives

Sukkar, B.

Phosphate-induced ORAI1 Expression and Store Operated Ca²⁺ Entry in Megakaryocytes

Sykora, K.-W.

The Evolution of Antibody Response during Immune Tolerance INDUCTION IN PAtients with Severe Hemophilia A Predicts Outcome

Szabó, G.

The Thrombin Generation Test: A Research Method or a Diagnostic Test?

Taleghani, M.M.

More severe ADAMTS13 Deficiency in Homozygous versus Compound Heterozygous Carriers of the ADAMTS13 c.4143_4144dupA Mutation in Congenital Thrombotic Thrombocytopenic Purpura (cTTP): Impact on Disease Onset?

Tanchanco, C.A.

Development of Deep Vein Thrombosis after Achieving Remission in a Patient with Acquired Hemophilia A

Successful Therapeutic Management and Delivery in a Pregnancy Complicated by Secondary Evans Syndrome from Systemic Lupus Erythematosus and Concurrent Antiphospholipid Syndrome

Tarakanchkova, Y.

The Kinetics of Platelet-derived Microparticles in Patients with ST Segment Elevation Acute Myocardial Infarction under Pharmacological Suppression of Platelet Aggregation

Tazina, E.

Correlation between Indicators of Endogenous Vascular Regulation and System of Hemostasis in Burn Patients

ten Cate, H.

Cost-effectiveness of a Telemedicine-based Coagulation Service versus Routine Medical Care for the Management of Patients Receiving Vitamin K-antagonists - Results from the thrombEVAL Study

The Relation between Coagulant and Vascular Function in Adult Survivors of Childhood Cancer

Terrell, D.R.

More severe ADAMTS13 Deficiency in Homozygous versus Compound Heterozygous Carriers of the ADAMTS13 c.4143_4144dupA Mutation in Congenital Thrombotic Thrombocytopenic Purpura (cTTP): Impact on Disease Onset?

Thakur, M.

Pancreatic Tumor Microvesicles Invade Immune Cells via CD36 and Distinctly Promote Tumor-associated Deep Vein Thrombosis

Thaler, J.

Intraperitoneal Activation of Blood Coagulation via Tissue Factor Exposing Extracellular Vesicles in Patients with Liver Disease and Ascites

Thiele, T.

Heterogeneity in Agonist-induced Activation Responses and Thrombus Formation: Differences between Large and Small Platelets

Cold Storage of Platelets in Additive Solution: The Impact of Residual Plasma in Apheresis Platelet Concentrates

Tiebel, O.

A New Rapid, Specific, and Simple ELISA for von Willebrand Factor Propeptide

Tiede, A.

Von Willebrand factor (vWF) Impairs FVIII-containing Immune Complex Formation and Attenuates Murine FVIII-specific Recall Response In vitro and In vivo

Baseline Data from a 24-month Prospective, Non-interventional, Multicentre Study in Germany to Evaluate the Real-world Usage and Effectiveness of rFVIIIFc and rFIXFc in Patients with Haemophilia A or B (PREVENT)

Tittl, L.

NOAC Therapy is also Effective and Safe in Patients Older than 80 Years - Results of the Prospective Dresden NOAC Registry (NCT01588119)

Treatment of VTE with Rivaroxaban in Adolescents - Preliminary Findings from the Prospective Dresden NOAC Registry (NCT01588119)

Tomalla, V.Y.

Inflammatory Function of Ribosomal RNA-containing Microvesicles from Mast Cells

Tomao, L.

Detection and Differential Diagnosis of Prekallikrein Deficiency: Genetic Study of New Families and Systematic Review of the Literature

Torge, A.

Recurrent Pediatric Stroke: The Role of Thrombophilia in a Large International Pediatric Stroke Population

Recurrent Pediatric Stroke: The Role of Thrombophilia in a Large International Pediatric Stroke Population

Torres, J.M.

Development of Deep Vein Thrombosis after Achieving Remission in a Patient with Acquired Hemophilia A

Tóth, J.

The Thrombin Generation Test: A Research Method or a Diagnostic Test?

Trabold, K.

The Direct Thrombin Inhibitors Dabigatran and Lepirudin Inhibit GPIbα-mediated Platelet Aggregation

Traby, L.

Risk and Determinants of Provoked Recurrent Venous Thromboembolism: A Prospective Cohort Study

Trautmann, K.

Changes in Hemophilia Treatment in Eastern Germany in the Last Decade - A Survey from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)

Changes in Hemophilia Treatment in Eastern Germany in the Last Decade - A Survey from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)

Tregel, M.

Changes in Hemophilia Treatment in Eastern Germany in the Last Decade - A Survey from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)

Changes in Hemophilia Treatment in Eastern Germany in the Last Decade - A Survey from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)

Trepels-Kottek, S.

Plasma-derived Factor X Therapy for Treatment of Intracranial Bleeding in a Patient with Factor X Deficiency: A Case Report

Trinchero, A.

Detection and Differential Diagnosis of Prekallikrein Deficiency: Genetic Study of New Families and Systematic Review of the Literature

Tuchin, V.

The Kinetics of Platelet-derived Microparticles in Patients with ST Segment Elevation Acute Myocardial Infarction under Pharmacological Suppression of Platelet Aggregation

Tullemans, B.

Heterogeneity in Agonist-induced Activation Responses and Thrombus Formation: Differences between Large and Small Platelets

Turpie, A.G.

Management of Venous Thromboembolism in Routine Clinical Practice - Results from the Global GARFIELD-VTE Registry

Ulehlova, J.

The Comparison of Manual and Automatic Interference Determination on Coagulometers ACL Top 750 CTS and Roche Cobas t511 for Routine Coagulation Tests

Ulrich, C.

Plasma Levels of Soluble CLEC-2 in Patients with Different Solid Tumors

Umansky, V.

Platelet-derived von Willebrand Factor Fosters Intracranial Hypercoagulation in Metastatic Brains of Mice and Humans

Urbschat, S.

Glioblastoma Cell Adhesion and Invasion in Fibrin is Promoted through β₃ Integrin

Vanassche, T.

Determinants of the Quality of Warfarin Control and Validation of the SAMe-TT2-R2 Score for Acute Venous Thromboembolism. An Analysis of the Hokusai-VTE Trial

van den, J. Boom

Baseline Data from a 24-month Prospective, Non-interventional, Multicentre Study in Germany to Evaluate the Real-world Usage and Effectiveness of rFVIIIFc and rFIXFc in Patients with Haemophilia A or B (PREVENT)

van Dorland, H.A.

More severe ADAMTS13 Deficiency in Homozygous versus Compound Heterozygous Carriers of the ADAMTS13 c.4143_4144dupA Mutation in Congenital Thrombotic Thrombocytopenic Purpura (cTTP): Impact on Disease Onset?

van Ryn, J.

The Direct Thrombin Inhibitors Dabigatran and Lepirudin Inhibit GPIbα-mediated Platelet Aggregation

Verma, D.

EPCR Raft Signaling Controls Activity of Hematopoietic Progenitor and Stem Cells

Verrel, F.

Severe Arterial Forearm Thrombosis in an 11-year-old Girl with Homozygous Antithrombin Deficiency typ IIb Budapest 3 and Mild Factor VII Deficiency Due to Homozygous Polymorphisms in the Factor 7 Gene and Antithrombotic Treatment

Veseley, S.K.

More severe ADAMTS13 Deficiency in Homozygous versus Compound Heterozygous Carriers of the ADAMTS13 c.4143_4144dupA Mutation in Congenital Thrombotic Thrombocytopenic Purpura (cTTP): Impact on Disease Onset?

Vetlesen, A.

In vitro and In vivo Validation of a Laboratory Assay for Monitoring Survival of Transfused Platelets: Tracking HLA Mismatch between Donor and Recipient

Vetr, H.

Performance Evaluation of the New Screening Assay for ADAMTS-13 Activity

Vlad, Radulescu

Results from a Phase 3, Randomized, Multicenter Study of Rurioctocog alfa Pegol PK-Guided Prophylaxis Targeting 2 FVIII Trough Levels in Patients with Severe Hemophilia a (Propel Study)

Voelkl, J.

Phosphate-induced ORAI1 Expression and Store Operated Ca²⁺ Entry in Megakaryocytes

Völkel, D.

Selective Measurement of Human Factor IX Padua Activity in Citrated Goat Plasma

Volkers, P.

Calcium Binding to FXIII-A Subunit: Unique Characteristics

Vollack, N.

Von Willebrand factor (vWF) Impairs FVIII-containing Immune Complex Formation and Attenuates Murine FVIII-specific Recall Response In vitro and In vivo

Vollenberg, R.

Anti-Glycoprotein V Autoantibodies in Patients with Immune Thrombocytopenia

Volles, L.

Results from a Phase 3, Multicenter, Noninferiority Study of Ravulizumab (ALXN1210) versus Eculizumab (ECU) in Adult Patients (pts) with Paroxysmal Nocturnal Hemoglubinuria (PNH) Naive to Complement Inhibitors (CI)

Vollmer, I.

Acquired von Willebrand Syndrome during Mechanical Circulatory Support and Extracorporeal Membrane Oxygenation: Rapid Onset and the Demand for Point of Care Testing

Volz, J.

Platelet Lamellipodia Formation is not Required for Thrombus Formation and Stability

Platelet Lamellipodia Formation is not Required for Thrombus Formation and Stability

von Auer, C.

Eleven Relapses in a Cohort of 78 Patients with Immune Thrombotic Thrombocytopenic Purpura (iTTP): Data from the German TTP-Registry

von Bargen, K.

Protocol for Safe Management of Patients under DOAC Therapy before Cardiothoracic Surgery Compared to Patients Undergoing VKA or No Anticoagulation Therapy

Establishment of Various Specific Parameters for the Routine Diagnostics in Patients with Glanzmann Thrombasthenia

Platelet Complement C3α-chain Differs from Plasma C3α

von Depka, M. Prondzinski

Thermography as a Component of Telemedicine for Diagnosis, Therapy and Follow-up of Joint Bleeding, Soft-tissue Bleeding and Micro-bleeding

Interim Results of a Non-interventional Study on Efficacy and Tolerability of a VWF/FVIII Concentrate in von Willebrand's Disease

Von Drygalski, A.

Phase 2b Trial of AMT-061 (AAV5-Padua hFIX): Translation into Humans of an Enhanced Gene Transfer Vector for Adults with Severe or Moderate-severe Hemophilia B

von Krogh, A.S.

More severe ADAMTS13 Deficiency in Homozygous versus Compound Heterozygous Carriers of the ADAMTS13 c.4143_4144dupA Mutation in Congenital Thrombotic Thrombocytopenic Purpura (cTTP): Impact on Disease Onset?

von Mackensen, S.

Development of an Adherence Questionnaire for Haemophilia Patients of the German Health System

Assessment of Joint Health in Children with Haemophilia - Results of the German Energy Study

von zur, C. Mühlen

Platelet-leukocyte Complex Formation is Associated with, but Dispensable for Myocardial Ischemia Reperfusion Injury

Vuimo, T.

Diagnostic Coagulopathy in Burn Patients in the Acute Period of Thermal Injury

Wagner, B.

The Relation between Coagulant and Vascular Function in Adult Survivors of Childhood Cancer

Wagner, L.

Determination of Age Dependent Reference Ranges for PT and aPTT

Performance Evaluation of Automated C1 Esterase Inhibitor Measurement with TECHNOCHROM®C1INH on Ceveron®alpha

Wallny, T.

Haemophilia and Osteoporosis Management in Germany

Walter, U.

The Direct Thrombin Inhibitors Dabigatran and Lepirudin Inhibit GPIbα-mediated Platelet Aggregation

Walzer, S.

Incidence of Acquired Thrombotic Thrombocytopenic Purpura Episodes in adults in Germany: Results of a Hospital Level Study and Projection to National Estimates

Wang, Y.

Increased Permeability of Tumor Blood Vessels is Triggered by Membrane Attack Complex Activated Neutrophils

Watters, G.

Effects of WSCM, eVCM and Nicotine on monocyte adhesion to human aortic endothelial cells

Watzka, M.

Determination of ɣ-carboxylation Pattern of Different Vitamin K Dependent Proteins with Respect to VKCFD1 Phenotype

Derivation of Patient Specific iPSCs and iHEP Cell Lines as a Tool to Investigate VKCFD2 in a Native Cellular Environment

Weber, A.

Selective Measurement of Human Factor IX Padua Activity in Citrated Goat Plasma

Selective Measurement of Human Factor VIII Activity in the Citrated Plasma of Laboratory Animals

Weber, C.

Pancreatic Tumor Microvesicles Invade Immune Cells via CD36 and Distinctly Promote Tumor-associated Deep Vein Thrombosis

Weber, C.F.

FibrinoQuick - A Rapid Fibrinogen Assay for Patient Blood Management

Weimer, T.

Improving the FVIII Binding Affinity of a Recombinant VWF D'D3-albumin Fusion Molecule Translates to Dosing Benefits with Respect to the Half-life Extension of Co-administered FVIII

Weiss, C.

Study Design for Evaluating an In Vitrodiagnostic Test for Direct Oral Anticoagulants

Weit, S.

A Laboratory Approach to Standardize Luminoaggregometry for Sample Shipment

Weitz, J.

Management of Venous Thromboembolism in Routine Clinical Practice - Results from the Global GARFIELD-VTE Registry

Wellhöfer, T.

A New Rapid, Specific, and Simple ELISA for von Willebrand Factor Propeptide

Wendisch, J.

Vaccination in Patients with Hemophilia - Results from an Online Survey among German Haemostaseologists

Wenning, S.

Haemophilia A Prophylaxis with FVIII in Real-life: Snapshot Analysis on the Observational Study “Prevention of Bleeding in Haemophilia A by Prophylactic Treatment with Octanate^®, Wilate^® or Nuwiq^® - NIS Previq”

Wermes, C.

Thermography as a Component of Telemedicine for Diagnosis, Therapy and Follow-up of Joint Bleeding, Soft-tissue Bleeding and Micro-bleeding

Comparison of Electronic Documentation with Smart Medication^tm between 2014 and 2017

Systematic Comparison of MRI and ultrasound scores to Assess Arthropathy in Children and Adolescents with Hemophilia

Treatment Pattern and Pain Related to Joint Bleeds and Non-joint Bleeds - real Life Data According to Electronic Diary Smart-medication^TM

Werner, C.

Activity of Maleimide Functionalized Unfractionated and Low Molecular Weight Heparins

Werner, Engl

Results from a Phase 3, Randomized, Multicenter Study of Rurioctocog alfa Pegol PK-Guided Prophylaxis Targeting 2 FVIII Trough Levels in Patients with Severe Hemophilia a (Propel Study)

Werwitzke, S.

Von Willebrand factor (vWF) Impairs FVIII-containing Immune Complex Formation and Attenuates Murine FVIII-specific Recall Response In vitro and In vivo

Wesche, J.

Single-molecule Labeling and Tracking of FcγRIIA on Human Platelets Reveals Differential Mobility Dynamics, which Depends on Platelet Cytoskeletal Integrity

Single-molecule Labeling and Tracking of FcγRIIA on Human Platelets Reveals Differential Mobility Dynamics, which Depends on Platelet Cytoskeletal Integrity

Westhoff, T.

Incidence of Acquired Thrombotic Thrombocytopenic Purpura Episodes in adults in Germany: Results of a Hospital Level Study and Projection to National Estimates

Wiegand, G.

Novel likely Pathogenic Variant in the Second Calcium Binding Domain of αIIb (Subunit of αIIbβ3) in a Patient with Glanzmann Thrombasthenia

Congenital Antithrombin Deficiency Type II: A Case Report

Wieland, I.

The Evolution of Antibody Response during Immune Tolerance INDUCTION IN PAtients with Severe Hemophilia A Predicts Outcome

Wienzek-Lischka, S.

Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT): Evidence that Placental rather than Systemic Inflammation is a Modulator of Disease Severity

Wild, P.

Cost-effectiveness of a Telemedicine-based Coagulation Service versus Routine Medical Care for the Management of Patients Receiving Vitamin K-antagonists - Results from the thrombEVAL Study

Wild, P.S.

The Relation between Coagulant and Vascular Function in Adult Survivors of Childhood Cancer

Willecke, F.

Platelet-leukocyte Complex Formation is Associated with, but Dispensable for Myocardial Ischemia Reperfusion Injury

Willemze, A.

Baseline Data from a 24-month Prospective, Non-interventional, Multicentre Study in Germany to Evaluate the Real-world Usage and Effectiveness of rFVIIIFc and rFIXFc in Patients with Haemophilia A or B (PREVENT)

William, Savage

Results from a Phase 3, Randomized, Multicenter Study of Rurioctocog alfa Pegol PK-Guided Prophylaxis Targeting 2 FVIII Trough Levels in Patients with Severe Hemophilia a (Propel Study)

Wilms, E.

The Gut Microbiota Restricts NETosis in Mesenteric Ischemia-reperfusion Injury

Wilson, M.

Improving the FVIII Binding Affinity of a Recombinant VWF D'D3-albumin Fusion Molecule Translates to Dosing Benefits with Respect to the Half-life Extension of Co-administered FVIII

Winkler, F.

Platelet-derived von Willebrand Factor Fosters Intracranial Hypercoagulation in Metastatic Brains of Mice and Humans

Winterhagen, F.I.

The Activated Protein C (APC) Response to In vivo Thrombin Formation Correlates with the Thrombotic Risk in Factor V Leiden but not in Prothrombin G20210A Carriers

Winterling, K.

Coagulation Factor VIII with Reduced Immunogenicity via a Direct De-immunization Approach

Wisgrill, L.

Intraperitoneal Activation of Blood Coagulation via Tissue Factor Exposing Extracellular Vesicles in Patients with Liver Disease and Ascites

Wislocka, L.

GECAT - German Evaluation of Cancer associated Thrombosis: A Prospective Register Trial for Patients with Active Cancer and Venous Thromboembolism in Berlin

Witkowski, J.

Using an Oligonucleotide-based Enzyme Capture Assay and Physiological Activation by the Thrombin-Thrombomodulin Complex Improves Protein C Deficiency Testing

Witt, L.

Bone Mineral Density and Bone Microstructure in Patients with Haemophilia in Northern Germany: Preliminary Findings of a Single Centre Study

LPS-induced Expression of Monocyte Tissue Factor (TF) Antigen Correlates with Markers of Systemic Inflammation in Patients with Hemophilia A and B

Woitas, R.

Incidence of Acquired Thrombotic Thrombocytopenic Purpura Episodes in adults in Germany: Results of a Hospital Level Study and Projection to National Estimates

Wolf, D.

Platelet-leukocyte Complex Formation is Associated with, but Dispensable for Myocardial Ischemia Reperfusion Injury

Wolf, K.

Platelet Serotonin in Arterial and Deep Vein Thrombosis

Wolf, M.

Incidence of Acquired Thrombotic Thrombocytopenic Purpura Episodes in adults in Germany: Results of a Hospital Level Study and Projection to National Estimates

Wolter, C.

Glioblastoma Cell Adhesion and Invasion in Fibrin is Promoted through β₃ Integrin

Wolters, E.

GECAT - German Evaluation of Cancer associated Thrombosis: A Prospective Register Trial for Patients with Active Cancer and Venous Thromboembolism in Berlin

Yan, S.

Systematic Review of Efficacy of Recombinant Factor IX Products for Prophylactic Treatment of Hemophilia B

Yang, Y.

The Endothelial Glycocalyx Contributes to the Anchorage of von Willebrand Factor Fibers to the Vascular Endothelium

Yuraszeck, T.

Population Pharmacokinetic Analysis of Recombinant Fusion Protein Linking Coagulation Factor IX with Recombinant Albumin (rIX-FP) in Adult and Pediatric Patients with Severe Hemophilia B

Zeitler, H.

Prompt Response and Long Term Remission of Refractory MGUS Related Acquired Hemophilia with Bortezomib

Cancer Induced Hyperfibronolysis in a 59-year-old Woman with Congenital Hyperfibrinogenemia

Experience in the Treatment of Acquired Haemophilia A (AHA) in 26 Patients in Relation to Bleeding Control and Induction of Immune Tolerance

Zelenkofske, S.

Phase 2b Trial of AMT-061 (AAV5-Padua hFIX): Translation into Humans of an Enhanced Gene Transfer Vector for Adults with Severe or Moderate-severe Hemophilia B

HOPE-B: Study Design of a Phase III trial of an Investigational Gene Therapy AMT-061 in Subjects with Severe or Moderately Severe Hemophilia B

Zellner, M.

Altered Protein Profiles in Platelets of Lupus Anticoagulant Positive Patients - New Players in LA-related Thrombosis?

Zhang, G.

Determinants of the Quality of Warfarin Control and Validation of the SAMe-TT2-R2 Score for Acute Venous Thromboembolism. An Analysis of the Hokusai-VTE Trial

Zhang, Y.

Population Pharmacokinetic Analysis of Recombinant Fusion Protein Linking Coagulation Factor IX with Recombinant Albumin (rIX-FP) in Adult and Pediatric Patients with Severe Hemophilia B

Zieger, B.

Novel likely Pathogenic Variant in the Second Calcium Binding Domain of αIIb (Subunit of αIIbβ3) in a Patient with Glanzmann Thrombasthenia

Detection and Differential Diagnosis of Prekallikrein Deficiency: Genetic Study of New Families and Systematic Review of the Literature

GEPHARD - the PUP Cohort of the `Standing Commission Paediatrics of the Society for Thrombosis and Haemostasis Research´ - A Progress Report

The First THROMKID-Plus Inter-laboratory Survey - Standardization and Quality Management of Platelet Light Transmission Aggregometry for the Diagnosis of Inherited Platelet Function Disorders in German-speaking Countries

The First THROMKID-Plus Inter-laboratory Survey - standardization and Quality Management of Platelet Light Transmission Aggregometry for the Diagnosis of Inherited Platelet Function Disorders in German-speaking Countries

Successful Treatment with Emicizumab of a Patient with Severe Haemophilia A and Factor VIII Inhibitors

Zipperle, J.

Plasmin-induced Alterations to Platelet GPIIb/IIIa Receptors Impair Secondary Blood Clot Firmness

Modified ROTEM^® xxtem Clotting Time Shows better Correlation with Endogenous Thrombin Potential than Standard Extem

Zirlik, A.

Platelet-leukocyte Complex Formation is Associated with, but Dispensable for Myocardial Ischemia Reperfusion Injury

Zittermann, A.

Protocol for Safe Management of Patients under DOAC Therapy before Cardiothoracic Surgery Compared to Patients Undergoing VKA or No Anticoagulation Therapy

Zlabinger, C.

Selective Measurement of Human Factor IX Padua Activity in Citrated Goat Plasma

Selective Measurement of Human Factor VIII Activity in the Citrated Plasma of Laboratory Animals

Zlamal, J.

Glycan Changes on Platelet and Megakaryocyte: A Potential Impact on Platelet Function and Lifespan in Immune Thrombocytopenia

Zobel, J.

Elevated Bile Acid Levels Induce Tissue Factor Activity in Hepatocytes